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Thesis outline 
 
“Metallo-β-lactamase-like enzymes from non-pathogenic organisms: an 
illustration of functional promiscuity” 
 
Chapter 1: A general overview about the family of metallohydrolases is 
followed by an up to date summary about the structure and function of the 
Zn-dependant metallo-β-lactamases (partially based on a published book 
chapter and mini-review); 
Chapter 2: Identification and preliminary characterization of novel B3-type 
metallo-β-lactamases (based on a published article);  
Chapter 3: β-Lactam antibiotic-degrading enzymes from non‐pathogenic 
marine organisms: a potential threat to human health (based on a published 
article); 
Chapter 4: Promiscuous metallo-β-lactamases: MIM-1 and MIM-2 may 
play an essential role in quorum sensing networks (based on a published 
article); 
Chapter 5: Probing the role of the metal ions in the mechanism of MIM-1 
and MIM-2 using spectroscopic and stopped-flow techniques (Publication in 
preparation); 
Chapter 6: Conclusions and future directions; 
Annex 1: Side projects and other published work.
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Abstract 
 
The spread of antibiotic resistance is one major global problem for healthcare systems. One of 
the most relevant mechanisms of resistance involves the expression, by bacteria, of enzymes able 
to degrade the antibiotic molecules. This thesis is focused on the study of a particular class of 
antibiotic-degrading enzymes, the metallo-β-lactamases (MBLs). MBLs are a family of Zn(II)-
dependent enzymes that inactivate most of the commonly used β-lactam antibiotics. In Chapter 1 
a detailed review of the properties of these enzymes is presented.  
Novel MBLs are continuously discovered and numerous variants of known MBLs 
emerge, largely due to the introduction and frequent misuse of novel antibiotics.  It has also 
become apparent that MBLs are present in microorganisms that are not pathogenic and inhabit 
environments that are not likely to be subjected to significant evolutionary pressures (such as the 
sharp increase in antibiotics).  MBLs from such environmental microorganisms may thus pose a 
future risk for health care, but they may also provide clues about essential factors that enable 
such enzymes to inactivate antibiotics.  In Chapter 2 the discovery of two novel putative MBLs 
from the marine organisms Novosphingobium pentaromativorans and Simiduia agarivorans is 
described.  In adherence with common practice these two enzymes were named Maynooth 
IMipenemase-1 (MIM-1) and Maynooth IMipenemase-2 (MIM-2), respectively.  
In Chapter 3 the biochemical properties of MIM-1 and MIM-2 are discussed and 
compared to those of known MBLs.  From the pH dependence of their catalytic parameters it is 
evident that both enzymes differ with respect to their mechanisms, with MIM-1 preferring 
alkaline and MIM-2 acidic conditions.  Both enzymes require Zn(II) but activity can also be 
reconstituted with other metal ions, including Co(II), Mn(II), Cu(II) and Ca(II).  Importantly, the 
substrate preference of MIM-1 and MIM-2 appears to be influenced by their metal ion 
composition, which may be a relevant factor in determining their precise biological function.  
Abstract 
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However, with respect to their catalytic efficiency towards degrading β-lactam antibiotics MIM-
1 and MIM-2 are comparable to MBLs from known pathogenic bacteria such as Klebsiella 
pneumonia or Pseudomonas aeruginosa.  They are also inhibited by the non-clinical compound 
D-captopril in a manner characteristic for MBLs.  Thus, even though MIM-1 and MIM-2 are 
currently not associated with antibiotic resistance these enzymes, should they ever enter the 
human population, certainly could pose a future threat to health care. 
Since neither N. pentaromativorans nor S. agarivorans are human pathogens, the precise 
biological role(s) of MIM-1 and MIM-2 remains to be established.  In Chapter 4 the possibility 
of an alternative function of MIM-1 and MIM-2 will be addressed. Although both protein 
sequence comparisons and homology modelling indicate that these proteins are related to well-
known MBLs such as AIM-1, the sequence analysis also indicates that MIM-1 and MIM-2 share 
similarities with N-acyl homoserine lactonases (AHLases) and glyoxalase II (GLX-II).  Steady-
state kinetic assays using a series of lactone substrates confirm that MIM-1 and MIM-2 are 
indeed efficient lactonases, with catalytic efficiencies resembling those of well-known AHLases.  
Interestingly, unlike their MBL activity the AHLase activity of MIM-1 and MIM-2 is not 
dependent on the metal ion composition with Zn(II), Co(II), Cu(II), Mn(II) and Ca(II) all being 
able to reconstitute catalytic activity (with Co(II) being the most efficient).  However, these 
enzymes do not turn over S-lactoylglutathione, a substrate characteristic for GLX-II activity.  
Since lactonase activity is linked to the process of quorum sensing the bifunctional activity of 
“non-pathogenic” MBLs such as MIM-1 and MIM-2 may provide insight into one possible 
evolutionary pathway for the emergence of antibiotic resistance.  
In the preceding chapters MIM-1 and MIM-2 were introduced as novel MBL-like 
enzymes that may provide essential clues about the functional promiscuity that may be inherent 
to the family of β-lactam-hydrolysing enzymes.  It is thus essential to probe the catalytic 
mechanism of these enzymes in detail to gain insight into essential factors that control their 
Abstract 
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reactivity.  In Chapter 5 a series of physico-chemical experiments are described (including rapid 
kinetics and spectroscopic techniques) that provide insight into the active site structure and the 
mechanism of substrate turnover.  In brief, while MIM-1 and MIM-2 employ a strategy that is 
similar to that of other MBLs by using a metal ion-activated hydroxide moiety to initiate the 
hydrolysis of β-lactam substrates (such as penicillin, cephalothin or imipenem) no reaction 
intermediate is observed.  Such an intermediate is present in many MBL-characterised reactions 
and indicates that MIM-1 and MIM-2 may use a different mechanistic strategy, one where the 
identity of the rate-limiting step is different from that of many (but not all) MBLs. 
 The characterisation of two novel members of the continuously growing family of MBLs 
has provided detailed insight into the structure and function of an antibiotic resistance 
mechanism that is not limited to pathogenic microorganisms.  The similarity of the physico-
chemical properties between MBLs from pathogenic and non-pathogenic sources may provide 
clues about evolutionary relationships that may underlie the rapid emergence and spread of 
antibiotic resistance, but it may also assist in the development of urgently needed potent and 
clinically useful inhibitors for this group of enzymes.  In Chapter 6 some concluding remarks 
allude to future directions in this area of research, including a brief description of the crystal 
structures of both MIM-1 and MIM-2, which have been solved by another member of our team 
as this thesis was being completed.  The hope remains that research like the one presented here 
will, in time, lead to a powerful strategy to combat the rise of antibiotic resistance and the grave 
dangers this brings to global human health. 
Chapter 1: An Introduction to metallo-β-lactamases and their role in the 
bacterial resistance to antibiotics 
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Chapter 1: An Introduction to metallo-β-lactamases 
and their role in the bacterial resistance to antibiotics. 
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Abstract  
Antibiotic resistance is one of the most significant challenges facing global healthcare. 
Since the 1940s, antibiotics have been used to fight infections, initially with penicillin and 
subsequently with various derivatives including cephalosporins, carbapenams and 
monobactams. A common characteristic of these antibiotics is the four-membered β-lactam 
ring. Alarmingly, in recent years an increasing number of bacteria have become resistant 
to these antibiotics. A major strategy em- ployed by these pathogens is to use Zn(II)-
dependent enzymes, the metallo-β-lactamases (MBLs), which hydrolyse the β-lactam ring. 
Clinically useful MBL inhibitors are not yet available. Conse- quently, MBLs remain a 
major threat to human health. In this review biochemical properties of MBLs are 
discussed, focusing in particular on the interactions between the enzymes and the func- 
tionally essential metal ions. The precise role(s) of these metal ions is still debated and may 
differ between different MBLs. However, since they are required for catalysis, their 
binding site may present an alternative target for inhibitor design.  
Keywords  
Antibiotic Resistance, β-Lactam Antibiotics, Metallo-β-Lactamases, Reaction Mechanism, Metal 
Ion Binding  
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Abstract  
At least one-third of enzymes contain metal ions as cofactors necessary for a diverse range 
of catalytic activities. In the case of polymetallic enzymes (i.e., two or more metal ions 
involved in catalysis), the presence of two (or more) closely spaced metal ions gives an 
additional advantage in terms of (i) charge delocalisation, (ii) smaller activation bar- riers, 
(iii) the ability to bind larger substrates, (iv) enhanced electrostatic activation of substrates, 
and (v) decreased transition-state energies. Among this group of proteins, enzymes that 
catalyze the hydrolysis of ester and amide bonds form a very prominent family, the 
metallohydrolases. These enzymes are involved in a multitude of biological functions, and 
an increasing number of them gain attention for translational research in medicine and 
biotechnology. Their functional versatility and catalytic proficiency are largely due to the 
presence of metal ions in their active sites. In this chapter, we thus discuss and compare the 
reaction mechanisms of several closely related enzymes with a view to highlighting the 
functional diversity bestowed upon them by their metal ion cofactors.  
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1.1. Metallohydrolases and the metallo-β-lactamase fold. 
 
The chemistry of life is complex. Many reactions, essential for basic and more advanced 
physiological functions, would not be possible without the support of enzymes. Enzymes are 
able to reduce the activation barrier of a reaction, thus accelerating reaction rates by many orders 
of magnitude. For this fundamental and vital ability, enzymes are both essential and ubiquitous 
in all the kingdoms of life [1, 2].   
 Enzymes are able to catalyze diverse reactions, being involved in a wide range of 
chemical pathways. For example, hydrolases are enzymes that are able to hydrolyze ester or 
amide bonds in specific substrates. Hydrolytic enzymes are involved in many physiological 
pathways and are necessary to recycle metabolites needed by the cells [1-3]. Among them, the 
binuclear metallohydrolases are a family of enzymes that use two metal ions in their catalytically 
active site in order to catalyze the hydrolysis of ester and amide bonds [1, 2, 4] (Figure 1.1.). 
The main ligands involved in metal ion coordination in these enzymes are the imidazole groups 
of histidine the acidic side chains of aspartate and glutamate, and the alcohol groups of tyrosine 
and serine [1, 2, 4]. Structurally, the two metal ions are separated by ~3.5 - 4 Å. It is common to 
find a bridging molecule between the two metal ions, generally an hydroxide (i.e., μ-hydroxide), 
the carboxyl side chain of an aspartate or glutamate or a combination of both. Frequently, the μ-
hydroxide acts as the nucleophile that initiates the chemical reaction [1, 2, 4]. The environment 
that is created by a bi-metallic centre presents numerous advantages in terms of its catalytic 
potential, including (i) charge delocalisation, (ii) smaller activation barriers, (iii) the ability to 
bind larger substrates, (iv) enhanced electrostatic activation of substrates, and (v) decreased  
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Figure 1.1. Binuclear metal ion centre representatives. A) pig PAP (PDB: 1UTE) [10], B) 
GpdQ from Enterobacter aerogenes (PDB: 3D03) [11], C) OPDA from Agrobacterium 
radiobacter (PDB: 2D2J) [12] and D) BcII from Bacillus cereus (PDB: 4C09) [13]. The amino 
acids involved in the metal binding are showed as sticks. In A) the Fe(II/III) and Fe(III) ions are 
depicted as orange spheres; in B) and C) the two metal ions are represented as pink spheres and 
labelled as α and β because of the promiscuity of these enzymes in respect of their metal cofactor 
requirements; in D) the two zinc ions are shown as grey spheres and the two sites are labelled as 
Zn1 and Zn2. The water molecules are represented as red spheres. The coordination involving 
the amino acids and the metal ions is shown with dashed blue lines, the interactions with the 
terminal water molecule are shown with dashed black lines. The image was generated using 
PyMOL. 
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transition-state energies [2, 4, 5]. 
The binuclear metal centre is associated with a variety of enzymatic structures, serving as 
the catalytic centre for many and diverse functions. Examples of protein folds possessing such a 
binuclear centre are the four-helix bundles (e.g., arginase), TIM barrels (e.g., the 
organophosphate (OP)-degrading enzyme from Agrobacterium radiobacter, OPDA), R/β/β/R 
folds (e.g., purple acid phosphatase, PAP, and the OP-degrading enzyme from Enterobacter 
aerogenes, GpdQ) and the αβ/βα fold (e.g., metallo-β-lactamases, MBLs) [1, 2, 4]. The scope of 
this chapter is to introduce the main features characteristic of MBLs, what is known about their 
structure to function relationship and the role(s) of the metal ion(s) in the catalysis. Over the last 
twenty years, these enzymes have acquired notoriety for their role in antibiotic resistance, a 
major challenge to current research endeavours in medicine and biotechnology [4]. 
The structural fold characteristic for MBLs was first identified in 1997 [6, 7]. Enzymes 
belonging to the MBL superfamily share a common three-dimensional structure as well as five 
conserved regions/motifs in their sequences, i.e. Asp84, His116-X-His118-X-Asp120-His121, 
His196, Asp221 and His263 (the standard BBL numbering scheme is used throughout this 
chapter and thesis [8]) [6, 9]. 
Despite their conserved fold, represented by the αβ/βα structure (Figure 1.2.), the primary 
sequences of different MBLs share only low sequence homology. Consequently, the MBLs 
possessing β-lactamase activity are divided into as many as four subgroups, i.e. B1 – B4  [6, 8, 
14].  It is also interesting to point out that while all known MBLs can accommodate two metal 
ions in their active sites, representatives of the B2 subgroup only need one metal ion for 
catalysis; the presence of the second metal ion leads to an inhibited state [6]. These variations 
may explain why MBLs are so effective in (i) inactivating most of the commonly used 
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antibiotics, (ii) adapting rapidly to new imposed challenges, and (iii) displaying functional 
promiscuity. 
Depending on their functions, members of the MBL super family – possessing the 
characteristic αβ/βα fold - can be divided into as many as 17 different  subgroups or classes 
including the β-lactam antibiotics-hydrolysing MBLs (group 1), the glutathione dependent 
glyoxalases II (group 2), the rubredoxin oxidoreductases (group 3), the t-RNA30 processing 
endo-ribonuclease tRNAseZ (group 4), members of the b-CASP family (groups 6 and 7), acid 
phosphorylcholine esterase Pce (group 9), N-acyl homoserine lactonases (group 12), 
alkylsulfatase from Pseudomonas aeruginosa SdsA1 (group 13) and the methyl parathion 
hydrolase (group 15). There is currently no structural information for the remaining groups [6]. 
The proteins belonging to group 1, i.e. the MBLs, are the subject of this thesis and will be 
introduced in detail in the remaining part of this chapter.  
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Figure 1.2. MBL structure. The figure shows the αβ/βα fold, characteristic of the MBL protein 
family. The structures shown are those of three representatives of the three major MBL classes. 
A) NDM-1 from Klebsiella pneumonia (PDB: 3ZR9) [15]; B) CphA from A. hydrophylia (PDB: 
1X8G); C) AIM-1 from P.aeruginosa (PDB: 4AWY). The representation shows the secondary 
structure elements as ribbon. The α-helix are coloured in green, the β sheet in red and the loops 
in grey. The zinc ions are shown as grey sphere; for NDM-1, the second ion occupying the active 
site is cadmium, shown as a yellow sphere. The black lines indicate the flexible loops, believed 
to play an important role in the substrate recognition in the B1- and B3-type MBLs. The image 
was produced using UCF Chimera 10.1. 
 
1.2. The spread of antibiotic resistance and the role of MBLs  
 
The first clinically available β-lactam antibiotic was introduced in 1940, when penicillin was 
first used to cure bacterial infections [16]. Since then, the chemical structure of β-lactam 
antibiotics (Figure 1.3.) has been extensively modified in order to obtain more powerful drugs, 
able to kill a wide range of pathogens. Unfortunately, careless use of antibiotics, combined with 
horizontal gene transfer between different bacterial strains, allowed the genes carrying antibiotic 
resistances to spread widely. In our modern era, we are facing a considerable risk to regress to a 
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time when bacterial infections would cause death at high rates.  
 β-lactam antibiotics have a common core structure, represented by the four-membered β-
lactam ring (Figure 1.3.), and can be divided into four main subgroups: penicillins, 
cephalosporins, monobactams and carbapenems. The β-lactams possess bactericidal activity. 
They inhibit cell wall formation and cause the formation of pores. Due to the difference in 
osmotic pressure between the external medium and the cytosol, they induce cell lysis due to the 
lack of a perfectly formed cell wall [17, 18].  
 Even though medicinal chemists have been working on the design of new and more 
efficient antibiotics, bacteria have continuously evolved ways to escape these antibiotics. 
Amongst the various possible pathways bacteria possess to fight antibiotics, one of the most 
efficient is the expression of hydrolytic enzymes able to hydrolyse most of the commonly used 
antibiotics. The enzymes able to hydrolyse β-lactams are called β-lactamases. These enzymes are 
able to cleave the cyclic amide bond, characteristic of the shared core structure of these 
antibiotics (Figure 1.3), thus inactivating the drug [18]. β-Lactamases are grouped into four 
subgroups, i.e. A, B, C and D. Subgroup B comprises MBLs [6, 18]. 
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Figure 1.3. β-lactam antibiotic core structures. The figure shows the core structure of the four 
major β-lactam classes. The image was generated using ChemDraw Professional 15.0. 
 
As discussed above, MBLs recruit up to two Zn(II) ion to hydrolyze β-lactams. In contrast, 
enzymes belonging to subgroups A, C and D do not require metal ions for their activity. They 
are called serine-β-lactamases (SBLs) and their mechanism employs an active site serine residue 
to initiate β-lactam hydrolysis [6]. Clinically useful inhibitors (e.g. clavulanic acid [19]) for 
SBLs are available, lessening their threat to health care [6, 19]. On the other hand, there are 
currently no clinically useful inhibitors for MBLs, compounding the threat these enzymes pose 
for global health [19, 20]. The scope of this thesis will focus on these enzymes. 
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1.3 Metallo-β-lactamases: a diverse group of enzymes 
 
Based on the sequence similarity, substrate specificity and metal ion requirements, the MBL 
family is further divided into four subgroups. Classes B1, B2 and B3 are well studied [6, 8, 21, 
22]. Recently, our group identified a fourth subgroup, termed B4. The first member to be 
identified in this subgroup is SPR-1 from Serratia proteomaculans [14, 23], that appears to be in 
a catalytically inactive mono-nuclear form in the resting state, but acquires a second metal ion 
when a substrate is added (substrate-promoted activation) [14, 23]. Insofar, SPR-1 resembles an 
organophosphate-degrading bimetallic glycerophosphate diesterase from Enterobacter 
aerogenes, GpdQ [11, 24, 25]. Since the discovery of SPR-1 several additional putative B4-type 
MBLs have been identified by sequence comparisons [14], however no structural information is 
currently available for any of these enzymes. Despite limited overall sequence homology and 
mechanistic differences the active site structures of all MBLs investigated to date reveal a 
common geometry that facilitates the accommodation of two closely spaced metal ions, although 
B2-type MBLs only require one metal ion for activity and B4-type MBLs may require a second 
metal ion only upon activation by the substrate (see above). Figure 1.4. illustrates active sites of 
representative MBLs from the B1, B2 and B3 subgroups. Table 1.1. summarises relevant amino 
acid ligands of the metal ions in the different subgroups. 
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Figure 1.4. Active site structure of MBL representatives. The active site structure of B1, B2 and B3 MBLs is show. A) B1 BcII from B. 
cereus, B) B2 CphA from A. hydrophylia, C) B3 AIM-1 from P. aeruginosa. The amino acids involved in the metal binding are shown as sticks. 
The zinc ions are shown as grey spheres, while the water molecules as red spheres. The blue dashed lines are used to show the amino acid to 
metal cooridinations; the Black dashed lines represent the interactions between the metal ions and the amino acids with the water molecules. 
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Table 1.1. Geometries and ligands of the two metal ion binding sites in MBLs from different subclasses. 
Subclass Zn1 Geometry Zn1 Ligands Zn2 Geometry Zn2 Ligands 
B1 Tetrahedral H116, H118, H196 & W1 Trigonal bipyramidal D120, C221, H263 & W1 
B2 Not occupied 
 
Tetrahedral D120, C221, H263 & W1 
B3 Tetrahedral H116, H118, H196 & W1 Trigonal bipyramidal D120, C221, H263, W1 & W2 
B4 Tetrahedral H116, R118, H196 Trigonal bipyramidal D120, Q121/S221, A262 
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Table 1.2. List of MBLs divided by class type. The Table presents a list of the B1-, B2- and B3-type MBL identified until now. The 
microorganisms from which the MBLs were first isolated are reported.  
MBL type Microorganism MBL type Microorganism MBL type Microorganism 
B1 
 
B2 
 
B3 
 
BcII Bacillus cereus CphA Aeromonas hydrophylia L1 Streptomonas maltophilia 
CcrA Bacteroides fragilis 
CphAII 
[26] 
Aquifex aeolicus FEZ-1 [27, 28] Fluoriobacter gormanii 
EBR-1 [29] Empedobacter brevis ImiS [30] Aeromonas sobria GOB-1 [31] Elizabethkingia meningoseptica 
BlaB [32] 
Elizabethkingia 
meningoseptica 
Sfh-I [33] Serratia fonticola AIM-1 Pseudomonas aeruginosa 
NDM-1 Klebsiella pneumoniae 
  
MIM-1 Novosphingobium pentaromativorans 
Acquired-B1 
   
MIM-2 Simiduia agarivorans 
IMP-1 Serratia marcescens 
  
SMB-1 [34] Serratia marcescens 
IMP-2 [35] Acinetobacter ssp 
  
SPR-1 Serratia proteamaculans 
VIM-1 [36] Pseudomonas aeruginosa 
  
CSA-1 Cronobacter sakazaki 
VIM-2 [37] Pseudomonas aeruginosa 
  
BJP-1 [38, 39] Bradyrhizobium japonicum 
SPM-1 [40] Pseudomonas aeruginosa 
  
CAR-1 [41] Erwinia carotovora 
GIM-1 [42, 43] Pseudomonas aeruginosa 
  
THIN-B [44] Janthinobacterium lividum 
DIM-1 [45] Pseudomonas stutzeri 
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1.4 MBLs in details: B1 and B3 subgroups 
The uncertainties regarding the number of zinc ions required in vivo by MBLs were further 
exacerbated by the first crystal structure obtained for the B1-type BcII from Bacillus cereus 
[46]. Although containing space for two zinc ions to be bound, the structure of BcII revealed 
an active site with only one zinc ion bound to the Zn1 site [46]. Since this structure became 
available, numerous studies have tried to establish the physiological metal composition of 
BcII, without success [47-49]. A factor that contributes to this lack in understanding is the 
absence of reliable data about the metal ion affinities to MBLs. It is apparent that metal 
binding affinities vary greatly depending on the technique used to analyze the binding 
phenomenon [16] (Table 1.3., Table 1.4., Table 1.5. and Table 1.6.). The B1 subclass is the 
most prevalent and structurally most extensively studied class of MBLs [6, 29, 46, 50-55] 
(Table 1.2.). Members include IMP [54, 56-63], VIM [64-72] and BcII [14, 18, 48, 73]. More 
recently, NDM-1 from Klebsiella pneumoniae emerged and made global headlines due to its 
highly pathogenic and dangerous nature because of its ability to degrade most commonly used 
antibiotics [74-79]. Examples of the B2 and B3 subgroups are CphA from A. hydrophila [80-
86], ImiS from A. veronii bv. Sobria and Sfh-I from S. fonticola [33, 82, 86], and L1 from S. 
maltophilia [87-90], FEZ-1 from F. gormanii [27], BJP-1 from B. japonicum [38], MIM-1 
from N. pentaromativorans [91, 92], MIM-2 from S. agarivorans [91, 92], SMB-1 from S. 
marcescens [93], CAR-1 from E. carotovora [41] and THIN-B from J. lividum [44]. The 
recently proposed B4 subgroup is represented by SPR-1 from S. proteamaculans [23] and 
CSA-1 from C. sakazaki [14] (Table 1.2.).  
 B1-type MBLs have two peptide loops, L3 and L8, in the vicinity of the metal ion-
containing active site (Fig. 1.2). These loops are believed to be crucial for the determination  
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of the substrate specificity of these enzymes [6]. In contrast, MBLs from the B2 subgroup 
lack the extended L3 loop. Instead these enzymes have a kinked α-helix positioned directly 
above the active site cleft [6, 94] (Fig. 1.2). This feature facilitates the formation of a narrow, 
well-defined substrate binding pocket. Consequently, these enzymes display a tighter 
selectivity for antibiotic substrates than other MBLs, hydrolysing only carbapenam substrates 
with high efficiency [6]. Of the three known representatives from this subgroup (Fig. 1.2 and 
Table 1.2), CphA is the most extensively studied [80-85, 95]. MBLs from the B3 subgroup 
also lack the extended L3 loop. However, they have an extra loop, located above the active 
site, which may also influence the substrate specificity of these enzymes. A preference for 
cephalosporins has been noted for this subgroup [6, 80]. Initially, SPR-1 from S. 
proteamaculans was also assigned to the B3 subgroup [23]. However, an analysis of its active 
site structure (Fig. 1.4), together with a homology sequence analysis has indicated that SPR-1 
may represent the prototype of the B4 subgroup of MBLs [14, 23]. Its substrate preference is 
similar to that of the B3-type MBL L1 from S. maltophilia [23]; no crystallographic data for 
SPR-1 is currently available.  
 Differences at the sequence level are not the only characteristic features that 
distinguish the three major subgroups. The metal ion content and the role(s) of the metal ions 
in catalysis also vary between the subgroups [16, 96, 97]. The B1- and B3-type MBLs 
generally require two zinc ions to work optimally, while the MBLs of the B2 subgroup only 
require one zinc (located in the Zn2 site) to be catalytically active (Fig. 1.4). The presence of 
a second zinc ion (in the Zn1 site) diminishes or inhibits enzyme activity [16, 96]. For 
example, when fluorescence spectroscopy was used to monitor the protein fluorescence, the 
binding constants for the Zn1 and Zn2 sites are 0.62 nM and 1.5 μM, respectively [48]. 
However, when the same binding interaction was studied using equilibrium dialysis,  
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corresponding values of 0.3 and 3 μM were reported [98] (Table 1.3., Table 1.4., Table 1.5. 
and Table 1.6.). Ignoring the variations of the magnitude of reported binding constants 
(which might be explained, at least in parts, by the use of different experimental conditions 
and/or different sensitivity of the technique used) the binding studies appear to be in 
agreement with the initial crystal structure of BcII: the two binding sites are distinct and 
possess different binding affinities. Moreover, it has been shown that the presence of the 
substrate can greatly enhance the affinity of the Zn1 binding site into the picomolar range, but 
have a modest effect on the affinity of the Zn2 site for the metal ion [99]. Since the 
physiological concentration of zinc in cells ranges from the femto- to the nanomolar range, 
the available metal ion binding constants suggest that BcII operates as mononuclear enzymes 
in vivo [99, 100]. The characterisation of an active mono-nuclear form of BcII was 
complicated by the observation that upon the addition of a single equivalent of zinc to apo-
BcII a mixture of two monometallic species was formed [48, 49, 98, 101]. Nonetheless, when 
the activity was measured under saturating [Zn(II)] condition, it doubled with respect to the 
mononuclear form of the enzyme, indicating that the catalytically optimal form of BcII is 
binuclear.  
The differences between MBLs are evident even within the same subgroup. In fact, 
other well-studied B1-type MBLs, e.g. CcrA from Bacteroides fragilis, tightly binds two zinc 
ions [102] (Table 1.3., Table 1.4., Table 1.5. and Table 1.6.). Kinetic studies have shown 
that only the binuclear form of CcrA is catalytically active. Previously reported activity of a 
putative mononuclear form was in fact the activity arising from a mixture of the apo- and 
binuclear forms of the enzyme [103, 104].  
 Similarly to the B1 class, proteins belonging to the B3-type MBLs display optimal 
activity in the bimetallic form (Table 1.3., Table 1.4., Table 1.5. and Table 1.6.). Another  
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characteristic shared with the B1 class is their broad substrate specificity. Despite these 
functional similarities, B1- and B3-type MBLs share only minimal overall sequence 
homology (20% or less) [105, 106]. Well-studied representatives of the B3 class are the 
proteins L1 from Stenotrophomonas maltophilia, FEZ-1 from Legionella gormanii and BJP-1 
from Bradyrizobium japonicum [28, 39, 107, 108]. The majority of the currently known B3-
type MBLs are believed to act as binuclear enzymes in vivo. The reported nanomolar affinities 
of their Zn1 and Zn2 sites support this hypothesis [28, 39, 107]. One notable exception is 
GOB-18 from Elizabethkingia meningoseptica which has maximum activity when only one 
zinc ion is bound to the Zn2 site [31, 109]. 
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Table 1.3. List of the metal binding constant for the Zn1 and Zn2 sites, obtained using competitive assays. Binding constants for B1-type MBLs. 
Enzyme Substrate 
Kd1 nM Kd1 nM Kd2 µM Kd2 µM 
Zn(II) Cd(II) Zn(II) Cd(II) 
 No 0.6 (± 0.1)[48]  1.50 (± 0.71)[48]  
  No 0.7 μM[110]   890 μM[110]   
BcII WT No 1.8 (± 0.3)[99] 8.3 (± 0.5)[48] 1.8 (± 0.3) μM[99] 5.9 (± 1.0)[48] 
  No     > 80 nM[111]   
  Imipenem 13.6 (± 5) pM[99]   0.8 (± 0.2) μM[99]   
H86S No 5.3 (± 2.3)[48]   0.3 (± 0.1)[48]   
H88S No 0.4 (± 0.1)[48] 3.8 (± 0.3)[48] 1.1 (± 0.2)[48] 1.4 (± 0.1)[48] 
H149S No 3.1 (± 0.1)[48]   0.2[48]   
D90N No 2.0 (± 0.4)[48]   5.0 (± 2.4)[48]   
C168S No 0.6 (± 0.2)[48]   2.3 (± 0.6)[48]   
C168A No ND   ND   
H210S No 0.4 (± 0.1)[48]   2.5 (± 0.5)[48]   
R121C No 3.6 µM[110]   570 µM[110]   
BcII-HS Nitrocefin    18 (± 12) µM[112]   
BcII-HD Nitrocefin    < 0.2 nM[112]   
BlaB 
No 5.1 (± 1.5) nM[99]   0.007 (± 0.002) µM[99]   
Nitrocefin 1.8 (± 0.2) pM[99]   0.025 (± 0.004) µM[99]   
NDM-1       2 µM[113]   
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Table 1.4. List of the metal binding constant for the Zn1 and Zn2 sites, obtained using competitive assays (continuation). Binding constants for 
B2- and B3-type MBLs. 
Enzyme Substrate 
Kd1 nM Kd1 nM Kd1 nM Kd1 nM Kd2 µM Kd2 µM Kd2 µM Kd2 µM 
Zn(II) Cd(II) Co(II) Cu(II) Zn(II) Cd(II) Co(II) Cu(II) 
CphA 
WT 
No 7 (± 2) [95] 
pM  
60 (± 10)  
pM[95] 
220 (± 25)  
pM[95] 
620 (± 55)  
pM[95] 
40 (± 6)  µM[95] 82 (± 8)  
µM[95] 
>5  mM[95] 
(pH 6.5) 
<10  µM[95] 
(pH 6.5) 
(pH 6.5) (pH 6.5) (pH 6.5) (pH 6.5) (pH 6.5) (pH 6.5) 
No 6 (± 2)  
pM[95] 
80 (± 72)  
pM[95] 
330 (± 40)  
nM[95] 
550 (± 58)  
nM[95] 
10 (± 3)  µM[95]   4 (± 2)  
µM[95] 
500 (± 48)  
µM[95] 
<20  µM[95] 
(pH 7.5) 
(pH 7.5) (pH 7.5) (pH 7.5) (pH 7.5)  (pH 7.5) (pH 7.5) (pH 7.5) 
Imipenem 1.2 (± 0.2) 
pM[99] 
      1.9 (± 0.3) 
µM[99] 
      
L1 WT 
No 2.6 (± 1.0) 
nM[99] 
      0.006 (± 0.002) 
µM[99] 
      
Imipenem 5.7 (± 2.0) 
pM[99] 
      0.12 (± 0.03) 
µM[99] 
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Table 1.5. Dissociation constants of Co(II) for the Zn1 and Zn2 sites of wild type and mutant BcII, determined using absorption spectroscopy 
[48]. 
Enzyme 
Kd1 µM 
Co(II) 
Kd2 µM 
Co(II) 
BcII WT 0.093 (± 0.015) 66.7 (± 10.0) 
H86S 10.5 (± 1.5) 
 
H88S 9.1 (± 1.1) 
 
H149S 2.7 (± 0.3) 
 
D90N 20.0 (± 3.5) 
 
C168S 3.1 (± 0.4) 
 
C168A 1.1 (± 0.1) 
 
H210S 0.35 (± 0.05) 
 
 
Table 1.6.  Second-order association rate constants of wild type BcII for the binding of Zn(II), Co(II) and Cd(II), followed by fluorescence 
spectroscopy [48]. 
 
Zn(II) Co(II) Cd(II) 
κon1 µM-1s-1 κon2 µM-1s-1 κon1 µM-1s-1 κon2 µM-1s-1 κon1 µM-1s-1 κon2 µM-1s-1 
14.1 (± 0.3)                       0.3 (± 0.01)                       26.0 (± 1.3)                      0.5 (± 0.01)                      
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1.5 MBLs in details: B2 subgroup 
 
B2-type MBLs require only one zinc ion coordinated to the Zn2 site for full catalytic activity 
[114] (Table 1.3., Table 1.4., Table 1.5. and Table 1.6.). When a second metal ion is bound 
to the Zn1 site, the activity is inhibited in a noncompetitive manner [115]. In contrast to the 
broad substrate specificity displayed by the B1 and B3 subclasses, the B2-type MBLs are 
strictly carbapenemase-specific [115]. Representatives of this group are ImiS from 
Aeromonas sobria, Sfh-1 from Serratia fonticola, and CphA from A. hydrophila [83, 116, 
117].  
The requirement for the B2-type MBLs for a mononuclear catalytically competent 
active site was supported by the crystal structure of CphA in complex with the substrate 
biapenem (Figure 1.5.). The crystal structure shows only one zinc bound to the Zn2 site [83]. 
Inhibition studies have led to the suggestion that when the Zn1 site is occupied by Zn(II), the 
catalytically relevant residues His118 and His196 are immobilized and the Gly232-Asn233 
loop folds into the active site, thus occluding the entrance to the substrate [6, 86]. The 
affinities of the Zn1 and Zn2 sites have been investigated by competition experiments, using 
the chromophoric chelator quin-2; the Zn2 site has a very high affinity for zinc (Kd < 10 pM), 
whereas the inhibitory Zn1 site has a considerably weaker affinity (~46 μM) for this metal ion 
[99, 115]. 
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Figure 1.5 Comparison of the complexes formed with the substrates and B1-, B2- and B3 
type MBLs (previous page). The figure shows the complex of NDM-1 from K. pneumonia 
with the substrate meropenem (blue) (PDB: 4EYL) [118], CphA from A. hydrophylia with the 
substrate biapenem (orange) (PDB: 1X8I) [83] and L1 from S. maltophilia with the substrate 
moxalactam (yellow) (PDB: 2AIO) [119]. The residues involved in the metal binding are 
shown coordinating the zinc ion present in the Zn2 site (represented as a grey sphere). The 
substrates are bound to the active site and positioned via the metal ion coordination. 
 
1.6 MBLs in details: B4 subgroup 
 
Recently, the discovery of a putative novel MBL from Serratia proteamaculans, SPR-1, 
further highlighted the functional differences within the MBL family. Preliminary 
spectroscopic and kinetic investigation led to the observation that SPR-1 may be mononuclear 
in its resting state. Only in the presence of the substrate the catalytically active binuclear 
center is formed, providing the platform for a substrate-mediated regulatory mechanism [23]. 
A similar behaviour was observed for the organophosphate-degrading enzyme GpdQ, thus 
suggesting an evolutionary link between metalloenzymes with largely different biological 
functions [2].  
The above discussion illustrates the diversity of various MBLs with respect to their 
interactions with their metal ion cofactors. Not surprisingly, the proposed reaction 
mechanisms employed by MBLs are equally flexible and have been shown to be influenced 
by a variety of factors including the source of the enzyme, the identity of the metal ion(s) 
bound to the active site and the substrate being turned over [22, 47, 56, 83, 108, 120]. 
However, the proposed models can be generally categorized as mono- and binuclear models 
and their overall features are briefly outlined in the following paragraphs.  
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1.7 Mono- and binuclear enzymes: two mechanisms, one reaction 
 
The mononuclear reaction model has been proposed using BcII from B. cereus as 
representative of the MBL proteins (Fig. 1.6.). The substrate cefotaxim makes contact in the 
active site exploiting both the hydrogen bond network involving the second ligand sphere 
residues Asn223 and Lys224, and an hydroxide coordinated by the zinc ion (Fig. 1.6.) [46, 
121]. This hydroxide is believed to initiate the nucleophilic attack on the β-lactam ring. It is  
oriented and stabilized by residues Asp120, Cys221 and His263, all Zn2 ligands in the B1- 
and B3-type MBLs, and Arg121 [48, 73]. The role of these residues is to activate the 
nucleophile, while the metal ion acts as a Lewis acid, increasing the nucleophilicity of the 
hydroxide. The combination of these interactions has been shown, by pH-dependent kinetic 
studies, to reduce the pKa of the nucleophilic water molecule from 15.7 to 5.6 [122]. Upon 
the nucleophilic attack a penta-coordinate transition-state may be formed, supported by 
computational but no experimental data to date [123]. The rate-limiting step is proposed to be 
the proton donation, from another Zn(II)-bound water molecule to the cyclic amide ring 
nitrogen [88] (Fig. 1.6.).  
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Figure 1.6. Mononuclear mechanism of β-lactam hydrolysis. Proposed reaction 
mechanism for mononuclear MBLs. The reaction is based on the crystal structure of mono-
zinc BcII from B. cereus. 
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The reaction between cefotaxime and the enzyme CcrA from B. fragilis served as a model to 
probe the binuclear mechanism employed by MBLs. The major difference between the mono- 
and binuclear mechanisms resides in the lower activation barrier required by the latter to 
perform the reaction (Figure 1.7.). 
When the second zinc is involved, the catalytic mechanism follows a quicker and more 
efficient single-step reaction [123-126]. Both Zn(II) ions in the active site coordinate the 
nucleophilic hydroxide. The presence of the second zinc decreases the electrostatic interaction 
between the water molecule and the substrate but, on the other hand, is compensated by the 
double-Lewis acid activation (Fig. 1.7.). Interestingly, it appears that the binuclear 
mechanism can occur in two alternative routes, one involving a tetrahedral reaction 
intermediate (e.g. NDM-1, L1, CcrA [127, 128]), and one involving no intermediate (e.g. 
Bla2). Furthermore, the B3-type MBL AIM-1 can utilize either route, although it is not yet 
understood what factors control the selection of the pathway [129]. 
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Figure 1.7. Dinuclear mechanism of β-lactam hydrolysis. Proposed reaction mechanism for dinuclear MBLs. The reaction is based on the crystal 
structure of di-zinc CcrA from B. fragilis. 
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In conclusion, the higher reaction rates and efficiencies observed for the binuclear systems 
can be explained by the lower activation barrier for the nucleophilic attack on the amide ring 
carbonyl group, and the more efficient protonation mechanism for the leaving product (Fig. 
1.7.) [123]. When looking at the entire MBL family, their rapid evolution can be partially 
explained by the evolutionary pressure to which these enzymes were subjected. Indeed, the 
uncontrolled usage of new antibiotics would have greatly accelerated this process, facilitating 
the appearance of many varieties of MBLs. Novel MBL-like proteins are frequently 
discovered that already contain an inherent ability to degrade a broad range of antibiotics via 
different mechanisms, using alterations of the same three-dimensional scaffold, with different 
metal ion requirements and different substrate-coordinating residues [21, 47, 98, 109, 117, 
123, 130]. It is possible that MBLs emerged from a range of progenitor enzymes that may 
have rather diverse and unrelated functions. This may explain why some MBLs are strictly 
mono-metallic, others are mono- and bimetallic and yet another group could be activated by 
converting a monometallic centre into a bimetallic one (see the discussion in the previous 
sections). The observed mechanistic versatility of the various members of the MBL family 
may also be a major, if not the major reason why it has been proven so difficult to establish 
clinically useful universal MBL inhibitors as drug leads to combat antibiotic resistance [20]. 
Developing an understanding of the factors that contribute to the mechanistic diversity among 
the MBLs is thus an important task in order to design new drugs to stop the spread of 
antibiotic resistance.  
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1.8 Conclusions 
 
MBLs have emerged as a major threat to global health. They inactivate an increasing number 
of commonly used antibiotics and spread easily among various pathogens on mobile genetic 
elements. Crystal structures for several MBLs have been determined and an extensive amount 
of information about their biochemical properties has been accumulated. Some potent in vitro 
inhibitors of MBLs have also been detected. However, to date none of the available MBL 
inhibitors are of clinical use. The search for universal and clinically applicable MBL 
antagonists is still very much at the beginning.  
This search is complicated further by the fact that MBLs are able to mutate rapidly and 
thus evade inhibition. This large mutational space is illustrated by the small degree of 
sequence and structure conservation in the substrate binding pockets of various MBLs; 
accordingly, their substrate preference and response to potential inhibitors can vary 
considerably. Thus, new strategies to comprehensively inhibit MBLs are needed. The main 
common aspect of their function is their requirement for metal ions, one (in the Zn2 site) for 
B2-type MBLs, and mostly two in the remaining ones (see discussion above). It is thus 
surprising that the precise role(s) of metal ions in the catalytic mechanism of MBLs, and in 
particular their binding interactions in the active sites are still obscure. It appears unlikely that 
the metal ion binding site can afford a large mutational degree of freedom - metal ion 
affinities are expected to be severely affected by most changes in their coordination 
environment. Hence, it is possible to propose that universal MBL inhibitors that may retain 
their effect long-term should target the metal ion binding site. It is thus essential to investigate 
and compare metal binding interactions among different MBLs under experimentally well-
defined and conserved conditions. A detailed characterisation of comparative metal ion  
affinities in various MBLs will provide essential information to design and develop 
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compounds that effectively interfere with metal ion binding in these enzymes. Such 
compounds are not expected to be affected by mutations as significantly as molecules that 
compete with substrates, and hence they may prove to be highly useful as clinical 
chemotherapeutics in the fight against antibiotic resistance.  
This thesis and the research project behind it started from the belief that understanding 
the role of the metallic centre for MBL function(s) is crucial to design strategies to effectively 
inhibit their catalytic action. In order to fully comprehend the role(s) of the metal ions in the 
mechanisms employed by MBLs two major questions need to be addressed: (i) how many 
metal ions bind under resting conditions, (ii) how many metal ions are required to achieve 
maximal activity and can this change depending on the substrate or other experimental or 
environmental (i.e. physiological) conditions, including changes in pH or temperature?  
The aim of this thesis is to address these questions, focusing on two recently 
discovered MBL-like proteins isolated from non-pathogenic, marine bacteria (see Chapter 2). 
In my studies I deliberately focused on two MBL-like proteins that already have the capability 
to degrade antibiotics without having experienced evolutionary pressures to do so. These 
enzymes may thus provide clues about intrinsic factors that constitute the minimal 
requirements for enzymes to have MBL-like activities. The two proteins were identified by a 
sequence homology search and are from now on referred to as Maynooth IMipenemases 1 
and 2, i.e. MIM-1 and MIM-2. 
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ABSTRACT  
Antibiotic resistance has emerged as a major global threat to human health. Among the 
strategies em- ployed by pathogens to acquire resistance the use of metallo-β-lactamases 
(MBLs), a family of dinuclear metalloenzymes, is among the most potent. MBLs are 
subdivided into three groups (i.e. B1, B2 and B3) with most of the virulence factors 
belonging to the B1 group. The recent discovery of AIM-1, a B3-type MBL, however, 
has illustrated the potential health threat of this group of MBLs. Here, we employed a 
bioinformatics approach to identify and characterize novel B3-type MBLs from 
Novosphingobium pentaro- mativorans and Simiduia agarivorans. These enzymes may not 
yet pose a direct risk to human health, but their structures and function may provide 
important insight into the design and synthesis of a still elusive universal MBL inhibitor.  
Keywords: Antibiotic Resistance; β-Lactam Antibiotics; Metallo-β-Lactamases; Sequence 
Homology; Novosphingobium Pentaromativorans; Simiduia Agarivorans 
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2.1 Introduction  
 
The introduction of β-lactam antibiotics (Fig. 1.2. - Chapter 1) in the 1940s has been 
considered as a breakthrough, if not the most significant breakthrough in the history of 
medicine. However, after only a few years penicillin resistance was observed in 
Staphylococcus aureus and meanwhile a large and increasing number of pathogens have 
acquired resistance to the most commonly used antibiotics [131, 132], triggering some experts 
to link antibiotic resistance to terrorism in terms of its global impact 
(http://www.bbc.co.uk/news/health-21737844). As outlined in Chapter 1, one of the most 
frightening forms of antibiotic resistance occurs through the action of MBLs, enzymes which 
are capable of breaking down most widely used β-lactam antibiotics [18, 132, 133]. The 
common features of MBLs were described in Chapter 1 [6, 18, 132, 134]. Most of the known 
MBL virulence factors belong to subgroup B1 and include BcII from B. cereus [46], CcrA 
from B. fragilis [102], as well as IMP-1 and SPM-1, both initially identified in P. aeruginosa 
[56, 135] (Table 1.2.). The recently identified NDM-1 (“New Delhi Imipenemase-1”) has 
acquired particular notoriety as it induces resistance to virtually all known β-lactam 
antibiotics [113]. Subgroup B2 enzymes share only ~11% sequence homology with B1-type 
MBLs, hydrolyse exclusively carbapenems (e.g. meropenem and imipenem) and require only 
one metal ion for catalysis [18, 95] (see Chapter 1, section 1.5, for more detailed information) 
[82, 116, 136]. Subgroup B3 is more closely related to B1-type MBLs rather than B2-type 
MBLs, requiring two bound metal ions for catalysis (Fig. 1.4. and Fig 1.5 in Chapter 1). The 
most studied representative is the tetrameric L1 from S. maltophilia [107]. Other members 
include FEZ-1 from L. gormanii [28], GOB-1 from E. meningoseptica (of which to date 18 
variants have been reported) [137] and SMB-1 from S. marcesens [34], the most recently 
identified MBL, which has a higher hydrolytic activity against a wide range of β-lactams than 
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other B3-type MBLs [34]. Of clinical relevance in particular is the enzyme AIM-1 from P. 
aeruginosa, which has been identified recently in a multi-drug resistant pathogen in a hospital 
in Adelaide, Australia (hence, the nomenclature of “Adelaide Imipenemase-1”—AIM-1) 
[138].  
Despite rather modest homology across their full length amino acid sequences MBLs 
share considerable similarities in their active site structures [18]. For more details regarding 
the metal ion compositions of the different subgroups refer to Chapter 1 (Fig. 1.4., and Table 
1.1.). As stated in the introductory chapter, the standard MBL numbering will be applied 
throughout the thesis [6, 139, 140]. In light of the rapid spread of antibiotic resistance and the 
increasing emergence of novel virulence factors (exemplified by NDM-1 and AIM-1), it is 
essential to identify novel putative MBLs, ideally before they become a threat to health care. 
Furthermore, novel MBLs may also provide essential insight into the structure and/or 
functional aspects relevant to the design and synthesis of universal inhibitors that may be 
clinically useful to combat antibiotic resistance. This chapter is focused on the discovery of 
two novel putative MBLs. specifically, a bioinformatics approach was employed to identify 
novel B3-type MBLs from Novosphingobium pentaromativorans and Simiduia agarivorans, 
two marine microorganisms that would have had minimal direct contact with the human 
population [141, 142]. These enzymes may not yet pose a direct risk to human health, but 
their structures and function may provide important insight into the design and synthesis of a 
still elusive universal MBL inhibitor.  
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2.2 Materials and Methods  
 
2.2.1 Selection of the Query Sequence and Protein Database Search Using BLAST  
 
The B3-type AIM-1 from P. aeruginosa was used as a query sequence for the protein 
database search. The protein sequence of AIM-1 was obtained from the Protein Data Bank 
(PDB; accession code: 4AWY), and the Basic Local Alignment Search Tool (BLAST; 
http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used to identify homologues. The two most 
promising candidates, from Novosphingobium pentaromativorans and Simiduia agarivorans, 
were selected for multiple sequence comparisons including known B3-type MBLs.  
2.2.2 Multiple Sequence Alignments  
 
Multiple sequence alignments including the novel B3-type MBLs and well known members 
of this group of enzymes (i.e. AIM-1 [138], L1 [107] and SMB-1 [34]) were carried out using 
ClustalW2, a multiple sequence alignment program, available via The European 
Bioinformatics Institute website (http://www.ebi.ac.uk /Tools/msa/clustalw2/).  
 
2.3. Results and Discussion  
 
2.3.1. Protein Database Search, Nomenclature and Classification of Novel MBLs  
 
Using the BLAST search engine with AIM-1 as the query two promising candidate sequences 
were retrieved, i.e. MBL-like sequences from N. pentaromativorans (accession code: 
ZP_09194167.1) and S. agarivorans (ac- cession code: YP_006917856.1). These 
microorganisms are both Gram-negative.  
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N. pentaromativorans is a poly-cyclic aromatic hydrocarbon-degrading bacterium [141], 
while S. agarivorans is a heterotrophic marine bacterium [142]. None of these organisms 
poses a direct current threat to human health, however, the observation that they harbour a 
potential MBL may not only foreshadow a future problem as they may represent a genetic 
“pool” for future modifications of MBLs that may enhance both their reactivity and 
evasiveness towards inhibition. It is thus essential to investigate the properties of these novel 
MBL-like proteins and compare them with those of well-known MBLs (e.g. AIM-1, L1 or 
SMB-1).  
As a step towards their characterization, the sequences of the N. pentaromativorans and S. 
agarivorans MBL-like proteins were compared with those of well-characterized MBLs from 
the B3 subgroup, i.e. AIM-1 [138], L1 [107] and SMB-1 [34]. The results from pairwise 
sequence comparisons are summarized in Table 2.1. Not surprisingly, the two sequences are 
most closely related to AIM-1. The MBL-like protein from N. pentaromativorans shares 53% 
sequence identity and 65% homology (including conserved amino acid substitutions) with 
AIM-1. The sequence identity/homology to the other two well characterized B3-type MBLs, 
L1 and SMB-1, is smaller (38%/54% and 41%/58%, respectively) but still strongly indicative 
that the N. pentaromativorans protein is indeed a B3-type MBL. In comparison, pairwise 
sequence comparisons with the B1-type NDM-1 and B2-type CphA indicate only 26%/39% 
and 23%/42%, respectively. A similar conclusion can be drawn for the MBL-like sequence 
from S. agarivorans. Its similarity/homology with AIM-1 (47%/64%) is less than that of the 
N. pentaromativorans MBL, but it appears to be more closely related to SMB-1 instead 
(Table 2.1.). The two MBL-like proteins share 47%/63% identity/homology in a direct 
pairwise sequence comparison. In summary, these pairwise comparisons strongly support the 
classification of these novel proteins sequences from N. pentaromativorans and S. 
agarivorans as MBLs from the B3 subgroup. In accordance with frequently applied 
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nomenclature procedures (e.g. “Adelaide IMipenemase-1” or AIM-1) the MBL-like 
sequences from N. pentaromativorans and S. agarivorans are labeled here “Maynooth 
IMipenemase-1” (MIM-1) and “Maynooth IMipenemase- 2” (MIM-2), respectively. 
 
Table 2.1. Pairwaise sequence comparison between MBL-like sequences from N. 
pentaromativorans (MIM-1) and S. agarivorans (MIM-2) and selected MBLs from the B1 
(NDM-1), B2 (CphA) and B3 (AIM-1, L1, SMB-1) subgroups. 
 MBL Identity (%) Homology (%) 
MIM-1 
AIM-1 53 65 
L1 38 54 
SMB-1 41 58 
NDM-1 26 39 
CphA 23 42 
MIM-2 
MIM-1 47 63 
AIM-1 47 64 
L1 33 51 
SMB-1 43 63 
NDM-1 37 59 
CphA 24 44 
 
2.3.2. Important Amino Acid Residues  
The above discussion demonstrated that the MBL-like sequences in the genomes of N. 
pentaromativorans and S. agarivorans are likely members of the B3 subgroup in the MBL 
family. However, in order to substantiate this interpretation, it is essential to ascertain whether 
amino acid residues that are essential for MBL function are conserved in the amino acid 
sequences of MIM-1 and MIM-2. The most relevant amino acid residues with respect to MBL 
function are those that form the metal binding site. Other residues in the proximity of the 
metal ion binding sites may be important for substrate or inhibitor binding or both. In order to 
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evaluate the functionality of MIM-1 and MIM-2 a multiple sequence alignment between these 
sequences and the structurally well-characterized AIM-1 [138], L1 [107] and SMB-1 [34] was 
carried out (Figure 2.1.). 
Importantly, the six amino acids that form the metal ion binding site are also invariant in both 
MIMs (i.e. His116, His118 and His196 in the Zn1 site and Asp120, His121 and His263 in the 
Zn2 site; see also Fig. 2.1.). Other amino acid side chains that were identified as important in 
MBL function are well conserved, including those in positions 221 (Ser) and 223 (Ser/Thr) 
that line the pocket where the β-lactam substrate may bind [18]. Tyr228, a residue that aids 
the polarization of the β-lactam carbonyl oxygen as a means to increase the susceptibility of 
the carbonyl bond for a nucleophilic attack by the “bridging” hydroxide is conserved in all 
MBLs compared here except AIM-1 (Fig. 2.1.). Conserved is also Trp39, another residue that 
has been shown to play an important role in substrate binding [143]. Furthermore, in AIM-1 
and to a large extent SMB-1 (but not L1) the structure of the enzyme is stabilized by the 
presence of three disulphide bridges (i.e. the pairs Cys32-Cys66, Cys208-Cys213 and 
Cys256-Cys290 [34, 138]). These six cysteine residues are conserved in both MIM-1 and 
MIM-2, suggesting that these enzymes possess a similar overall fold as AIM-1 and SMB-1.  
Some observed sequence variations may, however, deserve mentioning here as they may be 
significant for differences in substrate preference, inhibitor binding and/or catalysis (see also 
Chapters 3 and 4). The region between residues 152 and 164 forms a flexible loop that may 
clamp down on the bound substrate and thus assist catalysis [18]. In this loop, the degree of 
sequence conservation is low (Fig. 2.1.) which may indicate variations in substrate selection, 
catalytic efficiency and possibly also interactions with potential enzyme inhibitors.  
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Figure 2.1. Multiple sequence alignment between known (AIM-1, L1 and SMB-1) and 
putative (MIM-1 and MIM-2) B3-type MBLs. Amino acid side chains involved in Zn2+ 
binding are shown in yellow. Other relevant residues are also indicated in colour and 
described in the text. 
           39                 66 
AIM-1  DDAGWNDPAMPLKVYGNTWYVGTCGISALLVTSDAGHILVDAATPQAGPQILANIRALGFR 
L1     VDASWLQPMAPLQIADHTWQIGTEDLTALLVQTPDGAVLLDGGMPQMASHLLDNMKARGVT 
SMB-1  QDRDWSSPQQPFTIYGNTHYVGTGGISAVLLSSPQGHILVDGTTEKGAQVVAANIRAMGFK 
MIM-1  GREGWSHPAPPAHIYGNTWYVGTCGIASILVTSDDGHVLIDSGPADAAPLVLANIRKLGFD 
MIM-2  DWDAWDKPGPPFRVLGNTYYVGTCGIAAILITGDAGHVLIDSGTDRGAVIVRDNIARLGFS 
           *  *  *  :  .*  :**  ::::*:    *: *:*.     .  :  * :  *. 
 
               116 -  121                     152          164   
AIM-1  PEDVRAIVFSHEHFDHAGSLAELQKATGAPVYARAPAIDTLKRGLPDRTDPQFEVAEPVA 
L1     PRDLRLILLSHAHADHAGPVAELKRRTGAKVAANAESAVLLARG--GSDDLHFGDGITYP 
SMB-1  LSDVKYILSTHSHEDHAGGISAMQKLTGATVLAGAANVDTLRTGVSPKSDPQFGSLSNFP 
MIM-1  PADVRWILTSHEHHDHAGSIAELQKATGAQIAAVASARQVLESGKPSADDPQSGLIEGFP 
MIM-2  LSDVKILLHSHEHIDHVGGMASLQSLSGATLYASPAAAAVMRNGTAGEDDPQAGALASFP 
         *:: :: :* * **.* :: ::  :** : *       :  *     * : 
 
                                  196         208   213     221/223 
AIM-1  PVANIVTLADDGVVSVGPLALTAVASPGHTPGGTSWTWRSCEG-DDCRQMVYADSLTAIS 
L1     PANADRIVMDGEVITVGGIVFTAHFMAGHTPGSTAWTWTDTRN-GKPVRIAYADSLS--- 
SMB-1  GSAKVRAVADGELVKLGPLAVKAHATPGHTEGGITWTWQSCEQ-GKCKDVVFADSLTAVS 
MIM-1  PVHVARVLVDGDSVTLGRLALTVRETPAHSPGSASWTWQACDEAFTCRMIAYADSATTIS 
MIM-2  VARVGGLVNDGDQIALGNLRLTAYATPGHTPGALSWQWRACEE-DRCTTLVYADSLSPVS 
              : *   : :* : ...    .*: *. :* *           :.:*** : 
  
         228                        256    263    
AIM-1  DDVFRYSDDAAHPGYLAAFRNTLARVAALDCDILVTPHP 
L1     APGYQLQGNPRYPHLIEDYRRSFATVRALPCDVLLTPHP 
SMB-1  ADSYRFSD---HPEVVASLRGSFEAVEKLSCDIAIAAHP 
MIM-1  ADDYRFSD---HPDRIARIRTGLSRIAQLPCDILVTPHP 
MIM-2  AEGYRFNA---HPEYLQAYRLGLATLADLECDLLLTPHP 
          :: . :*  :   *  :  :  * **: :: ** 
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While there is currently no clinically useful MBL inhibitor available, mercaptoacetates 
(MCRs) are known to be potent in vitro inhibitors of some MBLs [144]. A recent 
crystallographic study with SMB-1 has shown that MCR interacts with active site residues 
Ser221 and Thr223 and has a Ki = 9.4 ± 0.4 μM (Fig. 2.1.) [34]. MIM-1 and AIM-1 have a 
sequence identical to that of SMB-1 in this so-called “MCR binding” region, whereas L1 and 
MIM- 2 have a Ser instead of Thr. Although this represents a conserved substitution, it may 
nonetheless be of significance as the different sizes of these side chains may affect the modes 
of substrate/inhibitor binding. Of particular interest may also be the residue in position 162, 
occupied by the bulky and nonpolar Phe residue in AIM-1, L1 and SMB-1, but by the small 
and polar Ser in MIM-1 and the small and nonpolar Ala in MIM-2. This residue lies within 
the flexible loop mentioned in the previous paragraph and may thus play an essential role in 
substrate and inhibitor binding.  
It is essential to characterize the properties of these novel B3-type MBLs to determine which 
of these variations are functionally relevant and in particular which of those may affect the 
mode and magnitude of inhibition by known inhibitors (such as MCR). Ultimately, it is 
anticipated that the functional and structural comparison of a multitude of related MBLs will 
identify residues that are suitable targets to develop universally applicable inhibitors that may 
be resistant to frequent mutational changes characteristic of this family of enzymes. 
Consequently, the following chapters focus on the enzymatic characterization of MIM-1 and 
MIM-2. 
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2.4. Conclusion  
The main finding of this study is the identification of two novel MBLs from N. 
pentaromativorans (MIM-1) and S. agarivorans (MIM-2) that belong to the B3 sub-group of 
this family of enzymes. Both proteins containing the amino acid ligands necessary to bind two 
zinc ions in their active sites and various residues in the vicinity of the catalytic centre are 
invariant or highly conserved, indicating that MIM-1 and MIM-2 should be efficient catalysts 
for the hydrolysis of β-lactam antibiotics. While MIM-1 and MIM-2 are not expected to 
represent an immediate threat to human health, they may harbour information that is crucial 
for 1) our understanding of the reaction mechanism(s) that MBLs may employ; and 2) the 
development of universal MBL inhibitors that are resistant to frequent mutational variations 
observed among members of this family of enzymes. This study is an initial step towards the 
characterization of these novel MBLs. Their recombinant expression and purification, as well 
as their catalytic and structural characterization are described in the chapters that follow.  
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Abstract Metallo-β-lactamases (MBLs) are a family of Zn(II)-dependent enzymes that 
inactivate most of the com- monly used β-lactam antibiotics. They have emerged as a 
major threat to global healthcare. Recently, we identi ed two novel MBL-like proteins, 
Maynooth IMipenemase-1 (MIM-1) and Maynooth IMipenemase-2 (MIM-2), in the 
marine organisms Novosphingobium pentaromativorans and Simiduia agarivorans, 
respectively. Here, we dem- onstrate that MIM-1 and MIM-2 have catalytic activities 
comparable to those of known MBLs, but from the pH dependence of their catalytic 
parameters it is evident that both enzymes differ with respect to their mechanisms, with 
MIM-1 preferring alkaline and MIM-2 acidic conditions. Both enzymes require Zn(II) 
but activity can also be recon- stituted with other metal ions including Co(II), Mn(II), 
Cu(II) and Ca(II). Importantly, the substrate preference of MIM-1 and MIM-2 appears 
to be in uenced by their metal ion composition. Since neither N. pentaromativorans nor 
S. agarivorans are human pathogens, the precise biologi- cal role(s) of MIM-1 and MIM-
2 remains to be established. However, due to the similarity of at least some of their in 
vitro functional properties to those of known MBLs, MIM-1 and MIM-2 may provide 
essential structural insight that may guide the design of as of yet elusive clinically use- 
ful MBL inhibitors.  
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3.1 Introduction  
As discussed in Chapter 1, one of, if not the most poignant problem for current global 
healthcare, is the rise of antibiotic-resistant microorganisms. In brief, since the 1940s 
antibiotics have been used to fight infections, initially with the β-lactam-based penicillin, and 
subsequently with various of its derivatives, including cephalosporins, cephamycins, 
carbapenems and monobactams (Figure 1.2 – Chapter 1). These compounds share a 
common core structure represented by the four-membered β-lactam ring. A major defence 
strategy employed by pathogens is to enzymatically hydrolyse this β-lactam ring, thus 
inactivating the antibiotics [19, 132, 145]. Two main enzyme groups have evolved for this 
purpose, the serine β-lactamases (SBLs) and the metallo-β-lactamases (MBLs). Clinically 
useful inhibitors are currently only available for SBLs [19, 20]; MBLs consequently remain a 
major threat to human health. In addition, the ability of MBLs to spread easily between 
species, mainly through horizontal gene transfer, further exacerbates the risk of generating 
multi-drug resistant pathogens [146-148].  
The task to develop universally and clinically useful MBL inhibitors is exacerbated by 
the continuous emergence of novel MBLs, exemplified by the broad-spectrum enzyme NDM-
1 [75, 113], and the frequent tolerance of a particular MBL to mutations as illustrated by the 
multiple variants of enzymes such as the NDM, IMP or VIM groups [58, 68]. Furthermore, 
the discovery of genes encoding MBL-like proteins in microorganisms that are not pathogenic 
and/or have not been exposed to the human population (e.g., the MBL-like proteins identified 
in microorganisms in the frozen Alaskan tundra [149]) may harbour clues about functionally 
essential elements that contribute to MBL activity. Identifying such elements may thus 
provide an alternative avenue to developing potent MBL inhibitors. In a recent study (see 
Chapter 2), we thus attempted to identify novel putative MBLs from non-pathogenic hosts 
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and identified MIM-1 from N. pentaromativorans and MIM-2 from S. agarivorans [91]. Little 
is known about these microorganisms, but both are Gram-negative bacteria found in marine 
environments [141, 142]. N. pentaromativorans is a poly-cyclic aromatic hydrocarbon-
degrading bacterium, while S. agarivorans is a heterotrophic bacterium; neither of these 
organisms is pathogenic [141, 142]. This Chapter will demonstrate the propensity of these 
enzymes to act as efficient MBLs and also how different metal ion compositions may affect 
the substrate preference of these enzymes, and thus potentially also their biological 
function(s). 
 
3.2 Materials and Methods  
 
3.2.1 Materials  
 
The sequences encoding MIM-1 and MIM-2 were cloned into the commercial vector pJ411 – 
the gene encoding MIM-1 and MIM-2 genes were commercially synthetized and bought as an 
expression vector from the company DNA 2.0. All chemicals were of analytical or equivalent 
grade. Escherichia coli BL21 (DE3) pLysS cells (Agilent) were used for recombinant 
expression of the proteins. All chemicals were purchased from Sigma-Aldrich unless stated 
otherwise.  
 
3.2.2 Protein expression and purification  
 
Recombinant MIM-1 and MIM-2 were expressed using Luria–Bertani (LB) medium 
supplemented with 0.2 mM Zn(II) and 1 % glucose. The cultures were grown at 37 °C until 
an optical density (OD600) of 0.4–0.5 was reached, and then cooled to 18 °C (MIM-1) or 25 
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°C (MIM-2) prior to induction with 0.2 mM isopropyl β-d-1-thiogalactopyranoside (IPTG). 
The cultures were further incubated for 48 h (MIM-1) and 18 h (MIM-2), respectively. The 
purification protocols for MIM-1 and MIM-2 are similar. The cells were harvested by 
centrifugation at 5000g for 20 min at 4 °C. The resulting pellet was resuspended in 15–20 mL 
of buffer containing 20 mM Tris (HCl; pH 7.0) and 0.15 mM ZnCl2. To improve the lysis 
step, lysozyme (1 mg/mL) was added to the resuspended cells, followed by incubation at 
room temperature for 30 min. Subsequently, DNAse (20 μg/mL) and MgCl2 (5 mM) were 
added and the mixture was kept on ice for 20 min. The cells were then disrupted using five 
rounds of sonication (60% of the maximal output power for 30 s in each round). The 
procedure was carried out on ice to avoid overheating of the cells. The lysate was centrifuged 
at 20,000g for 30 min and 4 °C, and then filtered through a 0.22 μm membrane (Millipore) to 
remove remaining debris. The supernatant was loaded onto a HiTrap Q FF 5 mL column (GE 
Healthcare), pre-equilibrated with 20 mM Tris (HCl; pH 7.0) and 0.15 mM ZnCl2. Proteins 
were eluted using a linear gradient from 0 to 0.5 M NaCl. MIM-1 eluted between 55 and 175 
mM of NaCl, while MIM-2 eluted between 35 and 135 mM of NaCl. The fractions possessing 
ampicillinase activity were pooled and loaded onto a HiPrep 16/60 Sephacryl S-200 HR 
column (GE Health- care), pre-equilibrated with 50 mM Hepes (pH 7.5) containing 0.2 M 
NaCl and 0.15 mM ZnCl2. Both proteins eluted as single peaks. SDS-PAGE analysis 
indicated that the purity of the enzymes is >95 % (Figure 3.1. SDS-PAGE). The protein 
concentrations were estimated using theoretical (calculated) extinction coefficients (ε280 = 
36,815 M−1cm−1 for MIM-1 and 41,285 M−1cm−1 for MIM-2), calculated from the 
sequence using the ProtParam webtool (http://web.expasy.org/ protparam/).  
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Figure 3.1. SDS-PAGE of MIM-1 and MIM-2. Lane 1a was loaded with the total protein 
fraction, 2a and 3a were loaded with the sample eluted after the anion exchange and after the 
size exclusion, respectively after MIM-1 purification. Lane 1b contains the total protein 
fraction, 2b and 3b contain the sample collected during MIM-2 purification after the anion 
exchange and the size exclusion, respectively.  M denotes the molecular weight markers. 
 
Both proteins are stable at 4 °C for at least two months (stored at a concentration of 10–20 
mg/mL). To assess the molecular weight and the oligomeric state of the proteins in solution, 
MIM-1 and MIM-2 (2 mg/mL) were loaded onto a gel filtration column, HiPrep 16/60 
Sephacryl S-200 HR (GE Healthcare), pre-equilibrated with 50 mM Hepes (pH 7.5), 0.2 M 
NaCl, 0.15 mM ZnCl2. The calibration curve (Figure 3.2.) was obtained using the Low 
Molecular Weight standards kit (GE Healthcare).  
 
3.2.3 Steady-state kinetics and substrate specificity of Zn-containing MIM-1 and MIM-2  
 
The β-lactamase activity of the proteins towards different substrates was measured 
spectrophotometrically by monitoring the depletion of these substrates (ampicillin, penicillin 
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G, biapenem, meropenem, imipenem, cefuroxime and cefoxitin) for 60 s at 25 °C and at the 
appropriate wavelengths. Relevant extinction coefficients and wavelengths are listed in Table 
3.1. Reactions were performed as a continuous assay in 50 mM HEPES (pH 7.5), 50 mM 
NaCl; rates were determined from the initial linear portion of the reaction progress curves. All 
the measurements were carried out using a Varian Cary 50-BIO spectrophotometer connected 
to a Peltier Thermostat system. The reactions were carried out without the addition of extra 
zinc to the buffer.  
 
Table 3.1. Wavelengths and the corresponding extinction coefficients of the substrates 
used in this study. 
Antibiotic ɛ (M-1cm-1) ʎ (nm) 
Biapenem 7600 293 
Meropenem 6500 300 
Imipenem 9000 300 
Ampicillin 820 235 
PenicillinG 936 235 
Cephalothin 6500 260 
Cefoxitin 7700 260 
Cefuroxime -7600 260 
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3.2.4 Kinetic data analysis  
 
Kinetic rate data (velocities) were analysed by non-linear regression using GraphPad (Prism) 
and t to either the Michaelis–Menten equation (Eq. 1) or an equation accounting for the 
observed substrate inhibition (Eq. 2). In these equations Vmax and Km are the maximum 
velocity and Michaelis constant, respectively, and Ki is the dissociation constant describing 
substrate binding to an inhibitory site [150]. The inhibitory effect of D-captopril on the MIM-
1- or MIM-2-catalyzed hydrolysis of ampicillin was assessed with inhibitor concentrations 
ranging from 0 to 20 μM. The inhibition constant (Kic, describing a competitive mode of 
binding) was obtained by analyzing the data with Eq. 3 [150]. The same experimental 
conditions were used to evaluate the catalytic parameters of metal ion derivatives of both 
MIM-1 and MIM-2, using Chelex-treated 50 mM Hepes buffer (pH 7.5), 50 mM NaCl, in the 
presence of CoCl2, MnCl2, CuCl2 or CaCl2 at  concentrations of 50 μM.  
 
                    (1) 
 
           (2) 
 
           (3) 
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3.2.5 pH dependence of catalytic parameters  
 
pH-rate profiles were determined using substrates representing three of the major β-lactam 
groups. The assays were conducted using a multi-component buffer system containing 50 mM 
sodium acetate, 50 mM MES, 50 mM TES, 50 mM CHES and 50 mM CAPS, in addition to 
50 mM NaCl and 50 μM ZnCl2. The pH dependence of the catalytic parameters was 
evaluated from rate measurements that were conducted at various pH values between 4.0 and 
10.0. The enzymes were stable over the entire pH range studied; auto-hydrolysis of the 
substrates was taken into account at each pH. The data were fitted using Graph Pad (Prism) 
and the appropriate equations derived for mono- or diprotic systems (i.e., Eqs. 4, 5), 
respectively) [150].  
 
            (4) 
 
         (5) 
 
In these equations, “a” represents the pH-independent maximum value of the catalytic 
parameter (i.e., kcat or kcat/Km), while Ka represents relevant acid dissociation constants; c is 
a fitting parameter.  
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3.2.6 Preparation of the metal ion-free apoproteins  
 
A protein sample (MIM-1 or MIM-2) was diluted in Chelex-treated metal ion-free buffer 
containing 50 mM Hepes (pH 7.5) and 50 mM NaCl, to a final concentration of 0.5–1 mg/mL, 
and then incubated in the presence of 150 mM EDTA at 4 °C for 48 h. The solution was then 
loaded onto an Econo-Pac 10DG (Bio-Rad) gel filtration column that was pre-treated with a 
chelating solution containing 5 mM EDTA, 5 mM 1,10-phenanthroline, 5 mM 2,6-pyridine 
dicarboxylic acid, 5 mM 8-hydroxyquinoline- 5-sulfonic acid, and 5 mM 2-mercaptoethanol, 
and then equilibrated with the Chelex-treated buffer prior to use. The residual enzyme activity 
of the collected apoenzyme was measured using ampicillin as the substrate and was found to 
be less than 1% of the maximum activity of the holo-enzyme, and atomic absorption 
measurements indicated that the metal ion content was below the detection limits of the 
apparatus. The addition of an excess of zinc restored at least 90% of the maximum activity.  
 
3.2.7 Estimation of metal ion binding affinities using reconstitution assays  
 
An estimate for the binding affinities of various metal ions (M = CoCl2, MnCl2, CuCl2, 
CaCl2 or ZnCl2) to MIM-1 and MIM-2 was obtained by recording catalytic activities as a 
function of added metal ion concentrations. The assay buffer containing 50 mM Hepes (pH 
7.5) and 50 mM NaCl was again treated with Chelex-100 to avoid any metal ion 
contaminations. Assays were carried out both in the absence and presence of 1 mM β-
mercaptoethanol in order to evaluate if a possible oxidation of Co(II) or Mn(II) may affect the 
activity of MIM-1 and MIM-2. Over several days the activities for each sample remained 
stable and β-mercaptoethanol did not lead to any measurable difference in catalytic rates. The 
concentration of the apoenzyme was kept constant at 10 nM while the substrate concentration 
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(i.e., ampicillin, biapenem and cefuroxime) was kept constant at two-fold the Km to avoid the 
effect of substrate inhibition. The metal ion concentration was gradually increased from 0 to 
100 μM. The addition of M(II) to the apo forms of MIM-1 and MIM-2 demonstrated 
saturation- type behaviour similar to that described by the Michaelis-Menten equation (Eq. 1). 
The data were analysed as previously reported [11].  
 
3.3 Results and Discussion  
 
3.3.1 Overexpression and purification of MIM-1 and MIM-2  
 
The genes harbouring the coding sequence of MIM-1 and MIM-2 were used to transform E. 
coli BL21 (DE3) pLysS cells. The expression vector (pJ411) uses a T7 promoter, and contains 
the kanamycin gene for the selection of transformants. To optimize the yield of pure protein, 
the expressions were carried out at low temperatures, 18 or 25 °C for MIM-1 and MIM-2, 
respectively. The established purification protocol employs two chromatographic steps, anion 
exchange followed by size exclusion. Routinely, purifications yielded approximately 15 mg 
of MIM-1 and 6.5 mg of MIM-2 per liter of cell culture with high purity (>95 %) as 
visualized by SDS-PAGE analysis (Fig. 3.1. - note that the calculated molecular weights for 
MIM-1 and MIM-2 based on their sequence are 30 and 29 kDa, respectively). To assess the 
oligomeric state of MIM-1 and MIM-2, size-exclusion chromatography with appropriate 
molecular weight markers was used. For MIM-1, a dimeric species is prevalent (~54 kDa), 
while MIM-2 appears to be monomeric (~27 kDa); (Fig. 3.2.). While the majority of known 
MBLs are also monomeric, the L1 enzyme from S. maltophilia is tetrameric [88]. 
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Figure 3.2. Equilibration curve (top panel) and elution profiles (bottom panel) of MIM-1 
(blue) and MIM-2 (red). The equilibration curve was determined using the commercially 
available Low Molecular Weight kit (Sigma-Aldrich) on a size exclusion column HiPrep 
16/60 Sephacryl S-200 HR column (GE Healthcare). MIM-1 elutes as a major peak with a 
corresponding weight consistent with the dimeric form of the protein (54 kDa). MIM-2 elutes 
as a major peak corresponding to a molecular weight of 27 kDa, consistent with the 
monomeric form of the enzyme. 
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3.3.2 Kinetic parameters of MIM-1 and MIM-2  
 
The aim of this work was to determine whether MIM-1 and MIM-2 are effectively able to 
hydrolyse β-lactam antibiotics. Thus, the catalytic efficiency of the two enzymes were studied 
towards different substrates representing three major groups of β-lactam antibiotics (i.e., 
penicillins, cephalosporins and carbapenems). For all the substrates used, both MIM-1 and 
MIM-2 showed considerable reactivity but at sufficiently high concentrations substrate 
inhibition was also observed (Figure 3.3. A). To obtain relevant kinetic parameters (kcat, Km, 
kcat/Km and Ki, the substrate inhibition constant), the catalytic rates were fitted using an 
equation that also incorporates an uncompetitive, inhibitory binding mode for the substrate 
(Eq. 2) [150]. For comparison, the rates measured at low substrate concentrations were 
analysed separately using the Michaelis–Menten equation (Eq. 1). The experimental data and 
corresponding fits are shown in Figure 3.3.A and Figure 3.3.B for MIM-1 and MIM-2, 
respectively. The relevant kinetic parameters are summarized in Tables 3.2. A and B. 
Corresponding parameters of well-known B3-type MBLs (i.e., L1 [107] and AIM-1 [138]), as 
well as those of the B1- and B2-type–type MBLs BcII [112, 151] and CphA [81], 
respectively, are also listed for comparative purposes (Table 3.2.C). Both MIM-1 and MIM-2 
are potent MBLs with catalytic parameters comparable to those of well-known virulent 
MBLs; both are in particular efficient penicillinases. Furthermore, similar to MBLs such as 
CcrA from B. fragilis, high concentrations of substrate lead to a reduction of the catalytic rate 
(deviation from Michaelis–Menten-type behaviour) [152]. 
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Figure 3.3. (A). Catalytic activity of MIM-1 towards the antibiotic penicillins (top), 
penems (middle) and cephalosporins (bottom). For each antibiotic, the data were analysed 
using the Michaelis–Menten model (for low substrate concentrations only; inset) and an 
equation that also incorporates an uncompetitive, inhibitory binding site for the substrate 
(main figure). 
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Figure 3.3. (B). Catalytic activity of MIM-2 towards the antibiotic penicillins (top), 
penems (middle) and cephalosporins (bottom). For each antibiotic, the data were analyzed 
using the Michaelis–Menten model (for low substrate concentrations only; inset) and an 
equation that also incorporates an uncompetitive, inhibitory binding site for the substrate 
(main figure).
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Table 3.2. Steady-state catalytic constants obtained for MIM-1 and MIM-2 incorporating (A) or neglecting the effect of substrate inhibition 
(B). For comparison, kinetics corresponding parameters for the well-studied MBLs L1 [39], AIM-1 [40], BcII [41, 42] and CphA [22] were 
included (C). 
  MIM-1 MIM-2 
Subsrate kcat (s-1)  KM (μM) kcat (s-1) /KM (s-1M-
1) 
KI (μM) kcat (s-1)  KM (μM) kcat (s-1) /KM (s-1M-1) KI (μM) 
Ampicillin 1995 ± 80.5 1011 ± 495 1.9 * 106 350.4 ± 190.5 701.3 ± 25.4 691.8 ± 31.1 1.06 * 106 402.8 ± 196.5 
Penicillin G 237.4 ± 55.6 167.2 ± 65.0 4.4 * 106 494.5 ± 201.6 244.9 ± 72.8 200.9 ± 10.4 1.2 * 106 766.7 ± 390.1 
Biapenem 143.1 ± 57.2 193.2 ± 57.2 7.4 * 105 95.3 ± 31.7 5.3 ± 0.3 84.1 ± 16.2 6.3 * 104 122.8 ± 87.6 
Imipenem 97.2 ± 74.3 123.6 ± 10.6 7.8 * 105 161.6 ± 14.8 6.9 ± 3.9 236.6 ± 16.4 2.9 * 104 73.6 ± 43.5 
Meropenem 53.9 ± 18.8 455.8 ± 19.4 1.1 * 105 248.6 ± 17.6 1.6 ± 0.2 28.2 ± 9.2 6.7 * 104 385.0 ± 118 
Cefuroxime 60.4 ± 13.1 55.6 ± 3.6 1.0 * 106 108.7 ± 35.7 98.1 ± 4.4 186.1 ± 10.5 5.2 * 105 71.7 ± 47.6 
Cefoxitin 1.8 ± 0.4 36.1 ± 1.4 4.9 * 104 100.3 ± 36.4 39.6 ± 11.9 81.3 ± 33.3 4.5 * 105 77 ± 33.9 
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Table 3.2. (B). 
Subsrate 
MIM-1 MIM-2 
kcat (s-1)  KM (μM) kcat (s-1) /KM (s-1M-1) kcat (s-1)  KM (μM) kcat (s-1) /KM (s-1M-1) 
Ampicillin 663.6 ± 42.7 226 ± 35.6 2.9 * 106 226.8 ± 6.5 141.6 ± 13.2 1.6 * 106 
Penicillin G 124.3 ± 3.9 50.7 ± 7.5 2.4 * 106 121.4 ± 2.1 36.4 ± 3.3 3.3 * 106 
Biapenem 52.6 ± 2.9 53.0 ± 7.1 9.9 * 105 5.3 ± 0.3 84.1 ± 16.2 6.3 * 104 
Imipenem 21.8 ± 1.7 186.7 ± 37.7 1.1 * 105 1.8 ± 0.1 34.2 ± 7.4 5.2 * 104 
Meropenem 20.7 ± 1.0 121.6 ± 17.4 1.7 * 105 1.2 ± 0.1 14.6 ± 2.2 8.2 * 104 
Cefuroxime 27.9 ± 0.8 15.0 ± 1.8 1.8 * 106 37.1 ± 2.3 53.4 ± 8.1 6.9 * 105 
Cefoxitin 1.0 ± 0.1 14.6 ± 2.2 6.8 * 104 17.2 ± 1.1 25.3 ± 4.7 6.8 * 105 
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Table 3.2. (C). 
AIM-1 L1 BcII CphA 
Substrate  kcat 
(s-1) 
KM (µM) kcat/KM  
(s-1M-1) 
kcat  
(s-1) 
KM (µM) kcat/KM  
(s-1M-1) 
kcat  
(s-1) 
KM (µM) kcat/KM  
(s-1M-1) 
kcat  
(s-1) 
KM (µM) kcat/KM  
(s-1M-1) 
Ampicillin 150 ± 5 24 ± 3 6.2 * 106 580 ± 20 300 ± 15 1.9*106 NA NA 8.2 * 104 >0.01 2500 >4 
Penicillin G 590 ± 31 110 ± 21 5.3 * 106 410 ± 20 300 ± 15 5.5*106 NA NA NA NA 700 100 
Biapenem NA NA NA 64 ± 4 75 ± 11 8.5 * 105 NA NA NA 300 166 1.8 * 106 
Imipenem 2200 ± 50 410 ± 16 5.3 ± 106 NA NA NA 279 687 1.4 * 105 1200 340 3.5 * 106 
Meropenem 760 ± 16 41 ± 4 1.8 * 107 NA NA NA NA NA NA NA NA NA 
Cefuroxime 170 ± 5 35 ± 4 4.8 * 106 53 ± 9 130 ± 40 4.0 * 105 NA NA NA NA NA NA 
Cefoxitin 52 ± 1 22 ± 2 2.4 * 105 2.2 ± 0.1 3.3 ± 0.4 6,6 * 105 122 ± 22 175 ± 43 6.9 * 105 NA NA NA 
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Due to the structural similarities between MBLs and some binuclear phosphatases such as the 
enzyme methyl parathion hydrolase [153] I tested if MIM-1 and MIM-2 may be able to 
hydrolyze generic phosphate ester substrates such as p-nitrophenyl phosphate (pNPP), bis(4-
nitrophenyl) phosphate (bpNPP) or paraoxon, but no quantifiable amount of product was 
formed in these reactions.  
To further validate the association of MIM-1 and MIM-2 with the MBL family, I analyzed the 
inhibitory effect of D-captopril, a well-known in vitro MBL inhibitor, but also an angiotensin-
converting enzyme (ACE) inhibitor used to treat hypertension and some heart-related diseases 
[20, 62, 154, 155]. The experimental data were consistent with a competitive mode of 
inhibition and fitted to Eq. 3 (Figure 3.4.). The inhibition constants (Kic) for both enzymes 
are approximately 6.0 μM, comparable to those reported for other MBLs (Table 3.3.) [20]. 
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Figure 3.4. Inhibition by D-captopril. Steady-state assays with the inhibitor were measured with the substrate ampicillin for MIM-1 (left) and 
MIM-2 (right). 
 
Table 3.3. Inhibition of MBLs by D-captopril. Competitive inhibition constants (Kic in μM) for MIM-1 and MIM-2 are compared to 
corresponding values for BcII, CphA and L1 
Inhibition by D-captopril 
MIM-1  MIM-2 BcII CphA L1 
8.8±0.9 7.4±0.8 45±5 72±6 20 
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3.3.3 Mechanism of action of MIM-1 and MIM-2  
 
The study of the effect(s) of pH on the catalytic properties of an enzyme-mediated reaction 
can provide essential clues about the molecular details of this reaction, but it can also 
highlight functional variations between different enzymes. Thus, steady-state assays as 
described above were carried out with MIM-1 and MIM-2 at a number of pH values, using 
representative substrates from three major groups of β-lactam antibiotics (Figure 3.5.). It is 
evident that the effect of the pH varies considerably when the two proteins are compared. As 
an example, the turnover numbers (i.e., kcat values) for each substrate tested are enhanced at 
high pH values in MIM-1-catalyzed reactions, but MIM-2 prefers a lower pH (i.e., an increase 
of pH leads to a reduction of the catalytic rate). In terms of the catalytic efficiency (kcat/Km), 
however, a higher pH appears to be preferred for both enzymes. Differences are also observed 
when the catalytic parameters measured with different substrates are compared. For instance, 
for MIM-1, the slope of the pH profile for the reaction with ampicillin is considerably smaller 
than 1, whereas for the other substrates it is approximating unity, suggesting that the rate-
limiting steps in the reactions with different substrates may vary (i.e., in the reaction with 
ampicillin the relevant protonation equilibria are not fully rate limiting [156]). Nonetheless, 
the data presented in Fig. 3.5. can be fitted to equations derived for mono- or diprotic systems 
(i.e., Eqs. 4, 5, respectively) and relevant pKa values are summarized in Table 3.4.  
The pH dependence of kcat provides information about catalytically relevant protonation 
equilibria for the enzyme–substrate (ES or Michaelis) complex [150]. The assignment of 
particular residues to experimentally determined protonation equilibria is generally a difficult 
task and fraught with ambiguities. However, from a direct comparison between substrates and 
enzymes, some essential insights may be gained (note that only biapenem has a pKa value that 
lies within the pH range relevant to MIM-1 and MIM-2 [157, 158]; see also Table 3.5.). 
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Figure 3.5. Effect of pH in the hydrolysis of ampicillin (green), biapenem (red) and 
cefuroxime (blue) for MIM-1 (left panel) and MIM-2 (right panel). For each substrate, the 
top panel shows the pH dependence of kcat and the bottom panel shows the pH dependence of 
kcat/Km. 
 
 
Table 3.4. pKa values for the hydrolysis of ampicillin, biapenem and cefuroxime by 
MIM-1 and MIM-2. 
 
MIM-1 MIM-2 
 
Ampicillin Biapenem Cefuroxime Ampicillin Biapenem Cefuroxime 
pKes1 7.7 ± 0.7 4.2 ± 0.5 4.7 ± 0.8 - - - 
pKes2 
  
9.5 ± 0.7 9.6 ± 0.3 7.9 ± 0.6 7.3 ± 0.2 
pKe1 6.4 ± 0.5 4.5 ± 0.2 4.6 ± 0.5 5.6 ± 0.2 5.1 ± 0.1 8.5 ± 0.4 
pKe2 
  
10.1 ± 0.5 9.6 ± 0.1 - - 
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Table 3.5. pKa values for the β-lactams used to study the pH dependence of MIM-1 and 
MIM-2 [156, 157]  
 
Antibiotic pKa 
Ampicillin 2.5-3.0 
Biapenem ~4.3 
Cefuroxime 2.0-2.5 
 
For MIM-1 pKes1 values determined for the reaction with biapenem and cefuroxime (~4.5) 
are similar, indicating that the relevant protonation equilibria are likely to be associated with 
the enzyme in both reactions, not the substrate. While a pKa of ~4.5 is consistent with the 
deprotonation of a metal ion-bridging water molecule, leading to the formation of a μ-
hydroxide (the proposed nucleophile in MBL-catalysed reactions [16, 18, 22, 96]), currently it 
cannot be excluded that a water molecule terminally coordinated to only one of the metal ions 
may be associated with pKes1, provided it is activated by the presence of negatively charged 
residues (e.g, carboxylate groups). In contrast, pKes1 recorded for the reaction with ampicillin 
is three orders of magnitude more alkaline, lying in the region anticipated for the pKa of a 
water molecule bound to only one of the metal ions in the active site, independent of the 
presence of “activating” negative charges or hydrogen bonds [159]. Thus, while an 
assignment of pKa values may ultimately need to be substantiated through site-directed 
mutagenesis studies it is evident that within the same active site different substrates are turned 
over in distinctly different ways. This is further corroborated by the observation that pKes2 is 
only observed for the reaction with cefuroxime.  
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For MIM-2, we will focus our attention solely on the pH dependence of the kcat values as 
they demonstrate the most significant variation in comparison to MIM-1 (Fig. 3.5.); the pH 
dependence of kcat/Km ratios is different for the three substrates but upon formation of the 
catalytically relevant Michaelis (ES) complex a similar behaviour is observed for each 
substrate. Only pKes2 is observed in MIM-2, contrasting sharply the corresponding data of 
MIM-1. As discussed above, pKa values in the range between 7.5 and 9.5 are consistent with 
terminally coordinated water molecules [159]. Thus, the pH profiles for MIM-2 do not 
provide any information about the potential reactive nucleophile (i.e., a bridging or terminally 
bound hydroxide), but they do indicate that the three substrates may bind in a similar mode in 
the catalytically relevant complex. The fact that in MIM-2 the nucleophile is not apparent in 
the pH profile (in contrast to MIM-1) indicates that the two enzymes have different rate-
limiting steps.  
The data in the preceding paragraph demonstrate a functional plasticity that appears to be very 
common among MBLs and MBL-like enzymes [16, 18, 22, 96], and which may be a major 
contributor to these enzymes’ ability to adapt rapidly to new environmental challenges (e.g., 
the use of novel antibiotics, or the introduction of inhibitors). MIM-1 and MIM-2, despite 
originating from non-pathogenic microorganisms, thus share the same functional diversity 
and/or flexibility as known MBLs.  
 
3.3.4 The role of the metal ions in the reactions catalyzed by MIM-1 and MIM-2 
 
The catalytically relevant in vivo metal ion for all known MBLs is Zn(II) [16, 18, 22, 96], but 
their contribution to the mechanism varies from one MBL subgroup to another (see Chapter 1, 
section 1.7, for detailed information regarding the MBL mechanism). Metal ion replacement 
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studies [including Mn(II), Co(II), Cd(II) and Cu(II)] were employed for several MBLs to 
probe the catalytic roles of the metal ions [16]. For MIM-1 and MIM-2, the native metal ion 
composition is not known. The enzymes were expressed and purified in medium and buffers 
that were supplemented with Zn(II), and metal ion analyses of these enzymes indicate the 
presence of two Zn(II) ions per active site in their fully active state. In an attempt (1) to probe 
the catalytic role(s) of the metal ions, but also (2) to address the likely in vivo metal ion 
composition of MIM-1 and MIM-2, the metal ion-free apo forms of the two enzymes were 
generated by incubation with the metal ion chelator EDTA. The removal of the metal ions did 
not result in structural damage of the enzymes as could be demonstrated by reconstitution of 
the catalytic activity upon addition of an excess of Zn(II). On average, between 90 and 95 % 
of the activity of the holoenzyme could be recovered; maximum activity was reached within 2 
min after the addition of the metal ion to the apoenzyme.  
Using the same batch of apoenzyme, derivatives were generated by adding Co(II), 
Mn(II), Cu(II) and Ca(II) and their catalytic parameters (Table 3.6.) were determined at pH 
7.5 for representative substrates from three major β-lactam groups (i.e., ampicillin, biapenem 
and cefuroxime). Although not shown here it should be noted that substrate inhibition similar 
to that observed for the Zn(II) derivatives of MIM-1 and MIM-2 was observed (Fig. 3.3 A 
and B). The metal ion derivatives are far more selective with respect to substrates they can 
hydrolyse when compared to the Zn(II) form of the enzymes. For instance, with respect to 
ampicillin, only Zn(II) can reconstitute activity in MIM-2, while for MIM-1 Ca(II) is also 
reasonably effective. For cefuroxime, only marginal activities were measurable for the Co(II) 
and Ca(II) derivatives. In contrast, all metal ion derivatives are active towards biapenem 
although, by and large, Zn(II) appears to be the most effective metal ion. The exception is 
Cu(II), which renders MIM-2 significantly more reactive than its Zn(II) counterpart (with kcat 
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values of 75 vs. 5 s−1, respectively). Furthermore, although Zn(II) is overall the most efficient 
metal ion in reconstituting activity, in the other derivatives, substrate affinities are mostly 
enhanced (i.e., reduced Km values).  
While the data in Table 3.6. indicate that with respect to the β-lactamase activity of MIM-1 
and MIM-2, Zn(II) is the preferred metal ion, they also demonstrate that substrate preference 
is affected by the metal ion composition, and thus alternative in vivo functions may be 
possible for these enzymes. A similar behaviour was observed previously for the B3-type 
MBL L1 from S. maltophilia, where the substrate specificity for the Ni(II) and Cu(II) 
derivatives of that enzyme varies distinctly from that of the Zn(II) derivative [160]. 
Here, a particularly intriguing observation was that Ca(II) was rather proficient in 
reconstituting ampicillinase activity in MIM-1 (Table 3.6.). While Ca(II) is known to bind 
tightly to regulatory proteins such as calmodulin (Kd for Ca(II) as low as 0.1 μM) [161] or α-
lactoalbumin (Kd 3–6 nM) [162], it is rarely associated with hydrolytic metalloenzymes. A 
notable exception is the cyclic nucleotide diesterase Rv0805 from Mycobacterium 
tuberculosis; in this enzyme Ca(II) does not only regulate catalytic activity but it is also the 
most optimal metal ion [163]. The significance of Ca(II) in a variety of metabolic functions 
(e.g., signal transduction, muscle contraction, fertilization, as well as maintaining the potential 
difference of the cellular membrane [164, 165]), together with its abundance in most cells, 
raises the possibility that at least MIM-1 may play a role in N. pentaromativorans that is not 
related to its in vitro MBL activity. 
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Table 3.6. Catalytic parameters for the hydrolysis of ampicillin, biapenem and cefuroxime by the Co(II), Mn(II), Cu(II) and Ca(II) derivatives 
of MIM-1 and MIM-2. 
MIM-1 
  Ampicillin Biapenem Cefuroxime 
 kcat (s-1) KM (µM) kcat/KM (s-1M-1) kcat (s-1) KM (µM) kcat/KM (s-1M-1) kcat (s-1) KM (µM) kcat/KM (s-1M-1) 
Co(II) NA NA NA 28.33 ± 2.2 103.2 ± 16.21 2.6 * 106 4.0 ± 0.4 9.43 ± 3.6 4.2 * 105 
Mn(II) NA NA NA 4.6 ± 0.9 268.2 ± 85.9 1.7 * 104 NA NA NA 
Cu(II) NA NA NA 103.1 ± 18.3 211.7 ± 73.2 4.6 * 105 NA NA NA 
Ca(II) 53.0 ± 7.8 261.2 ± 91.9 2.0 * 105 8.6 ± 0.3 20.9 ± 3.8 4.1 * 105 3.3 ± 0.1 7.8 ± 1.4 4.6 * 105 
MIM-2 
 kcat (s-1) KM (µM) kcat/KM (s-1M-1) kcat (s-1) KM (µM) kcat/KM (s-1M-1) kcat (s-1) KM (µM) kcat/KM (s-1M-1) 
              
Co(II) NA NA NA 1.2 ± 0.1 25.8 ± 7.9 4.6 * 104 1.1 ± 0.3 36.3 ± 2.39 3.0 * 104 
Mn(II) NA NA NA 1.7 ± 0.2 43.4 ± 15.9 3.7 * 104 NA NA NA 
Cu(II) NA NA NA 75.4 ± 7.2 164.2 ± 34.2 4.5 * 105 NA NA NA 
Ca(II) NA NA NA 0.8 ± 0.1 11.4 ± 8.6 7.2 * 104 1.6 ± 0.4 62.7 ± 23.2 2.5 * 104 
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To be physiologically relevant, the binding affinity of a metal ion for a particular protein 
ought to be within a range that is similar to the concentration of that metal ion within a cell. 
The concentrations of metal ions vary greatly from one metal ion to another, and they can 
change throughout the life cycle of a cell. Reported concentrations for Zn(II), Mn(II), Cu(II) 
and Ca(II) are covering a range from pico- to micro- molar, while Co(II) is a trace element 
[166]. We obtained an estimate of the binding affinities of MIM-1 and MIM-2 for the 
biologically potentially relevant metal ions [i.e., Zn(II), Mn(II), Cu(II) and Ca(II)] by 
measuring their catalytic activities towards biapenem degradation as a function of added 
metal ion concentrations. Although unlikely to be physiologically relevant, Co(II) was 
included in the comparison as it may provide a useful spectroscopic probe for future 
mechanistic studies. As exemplified in Figure 3.6., the reactivation of the apo forms of MIM-
1 and MIM-2 upon titrating increasing amounts of the metal ions resulted in a saturation-type 
behaviour for the catalytic activity, reminiscent of Michaelis–Menten-type kinetics (to avoid 
substrate inhibition the substrate concentration was two-fold the respective Km). 
Since the reconstitution experiments were conducted under pseudo-first-order kinetics 
and the metal ion concentrations far exceeded those of the enzymes, no accurate estimate of 
the stoichiometry of metal ion binding can be obtained—instead atomic absorption 
measurements of fully reconstituted enzyme samples, following a gel filtration step to remove 
excess metal ions, indicated a stoichiometry of ~2 in each case. An approximation of the 
affinities of the catalytically required metal ions (Table 3.7) can be estimated from a fit to the 
data in Fig. 3.6. using a hyperbolic function related to the Michaelis–Menten equation. 
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Figure 3.6. Analysis of the titration curve of apo-MIM-1 and apo-MIM-2 in the presence 
of increasing concentrations of zinc. The reactivation of the enzyme is followed by the 
hydrolysis of ampicillin. In the case of Zn(II) Kd values are 0.2 and 1.7 μM for MIM-1 and 
MIM-2, respectively.  
 
Table 3.7. Binding affinity constants for the metal derivatives of MIM-1 and MIM-2. 
MIM-1 MIM-2 
kobs (µM) kobs (µM) 
Zn(II) Co(II) Mn(II) Cu(II) Zn(II) Co(II) Mn(II) Cu(II) 
204 ± 72 
(nM) 
4.3 ± 
0.8  
662 ± 251 
(nM) 
10.3 ± 
2.8 
1.7 ± 
0.4 
12.14 ± 
4.1  
NA 108 ± 
93.8  
 
Overall, MIM-1 has a higher affinity for all the metal ions under investigation, and Zn(II) is 
the most tightly bound metal ion in both enzymes. Based on these affinity data and the 
catalytic parameters summarized in Table 3.6., it is thus likely that MIM-2 is solely a Zn(II)-
dependent enzyme. However, the binding affinities of Mn(II) and Ca(II), and potentially 
Cu(II) are within a reasonable range to be biologically relevant, thus supporting the above 
speculation that at least MIM-1 may adopt biological roles independent of its MBL activity. 
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3.4 Conclusions.  
In this chapter I presented data that confirm that the putative proteins MIM-1 and MIM-2, 
associated with non-pathogenic microorganisms, are indeed efficient in vitro MBLs. The 
catalytic parameters of MIM-1 and MIM-2 are comparable with those reported for clinically 
relevant MBLs, thus confirming the potential of these proteins as novel enzymatic agents, 
able to confer efficient resistance toward β-lactam antibiotics. The observed mechanistic 
plasticity of MIM-1 and MIM-2 is characteristic for MBLs, but the efficient use of Ca(II) as 
catalytically competent metal ion by MIM-1 has not been observed before. This leads to the 
hypothesis that at least MIM-1 may have biological functions unrelated to its MBL activity. 
The search for alternative substrates (i.e., substrates other than β-lactam antibiotics) is thus of 
importance and will be described in the next chapter. Especially the observation that different 
metal ion compositions may affect the selection of substrates (and thus the function of the 
enzymes), together with a possible association between some MBLs [167] with proteins 
involved in biofilm production may provide insight into a previously unexplored link between 
two major factors that contribute to antibiotic resistance. Although the establishment of the 
precise biological function(s) of MIM-1 and MIM-2 awaits further investigations, it is 
anticipated that a characterization of factors that lead to functional variations between closely 
related enzymes may guide future strategies for the development of leads (i.e., clinically 
useful MBL inhibitors) to combat the spread of antibiotic resistance.  
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Functional promiscuity  
Abstract MIM-1 and MIM-2 are two recently identified metallo-β-lactamases (MBLs) 
from Novosphingobium pentaromativorans and Simiduia agarivorans, respectively. 
Since these organisms are non-pathogenic we specu- lated that the biological role(s) of 
MIM-1 and MIM-2 may not be related to their MBL activity. Although both se- quence 
comparison and homology modeling indicate that these proteins are homologous to well-
known MBLs such as AIM-1, the sequence analysis also indicated that MIM-1 and 
MIM-2 share similarities with N-acyl homoserine lactonases (AHLases) and glyoxalase 
II (GLX-II). Steady-state kinetic assays using a series of lactone substrates confirm that 
MIM-1 and MIM-2 are efficient lactonases, with catalytic efficiencies resembling those 
of well-known AHLases. Interestingly, unlike their MBL activity the AHLase activity of 
MIM-1 and MIM-2 is not dependent on the metal ion composition with Zn(II), Co(II), 
Cu(II), Mn(II) and Ca(II) all being able to reconstitute catalytic activity (with Co(II) 
being the most efficient). However, these enzymes do not turn over S-lactoylglutathione, 
a substrate characteristic for GLX-II activity. Since lactonase activity is linked to the 
process of quorum sensing the bifunctional activity of “non-pathogenic” MBLs such as 
MIM-1 and MIM-2 may provide insight into one possible evolutionary pathway for the 
emergence of antibiotic resistance.  
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4.1 Introduction 
Antibiotic resistance is a major problem for modern health care systems across the globe. A 
major strategy employed by pathogens to acquire resistance to commonly used antibiotics 
involves the use of enzymes that inactivate these compounds. Of particular concern are the 
metallo-β-lactamases (MBLs), a large group of enzymes that are highly efficient in 
inactivating the majority of the available β-lactam-based antibiotics (e.g. penicillins, 
cephalosporins, carbapenems; refer to Fig. 1.3. in Chapter 1 for β-lactam core structures). Not 
only are these enzymes highly efficient catalysts, but there is also currently no clinically 
useful inhibitor available [16, 18, 20, 96, 132]. Novel MBLs are frequently discovered (e.g. 
NDM-1 or AIM-1 [113, 138]) and horizontal gene transfer further exacerbates the problem of 
a rapid spread of MBLs among pathogenic bacteria [146-148]. MBLs belong to a large group 
of metal ion-dependent hydrolytic enzymes (i.e. metallohydrolases) that include, among 
others, amino-peptidases, pesticide-degrading enzymes and numerous phosphatases [2, 4, 96]. 
The identity of the metal ions used by metallohydrolases varies considerably. For instance, 
urease has a specific requirement for two Ni(II) ions [168], while purple acid phosphatases 
(PAPs) contain a heterovalent Fe(III)-M(II) centre, where M = Fe, Zn or Mn [4, 96, 169]. 
Interestingly, in animal PAPs the divalent metal ion is exclusively Fe, which can easily and 
reversibly be oxidized, leading to the speculation that this enzyme may also act as a Fenton 
catalyst in vivo [170]. Other metallohydrolases such as a glycerophosphate diesterase (GpdQ) 
from Enterobacter aerogenes or an organophosphate (OP)-degrading enzyme from 
Agrobacterium radiobacter (OPDA) are highly promiscuous with respect to metal ions they 
can utilize for their catalytic functions [11, 24, 25, 171-174] (refer to Chapter 1 for more 
details regarding metallohydrolases). In contrast, the in vivo metal ion associated with MBLs 
is exclusively Zn(II), but in vitro assays have demonstrated that other divalent metal ions such 
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as Co(II), Mn(II) or Ca(II) can reconstitute full or partial catalytic activity [89, 92, 175]. The 
crystal structures of several MBLs have been reported [16, 54, 77, 86, 138] (Fig. 4.1.); 
interestingly, the fold characteristic for MBLs is also used by metalloenzymes with rather 
different functions, including the organophosphate-pesticide degrading enzyme methyl 
parathion hydrolase [153, 176] and enzymes involved in quorum quenching (QQ) [9, 177].  
QQ is used by bacteria to regulate quorum sensing (QS) networks [177-181]. QS is defined as 
an effect on a population of unicellular organisms that triggers them to act as a multicellular 
organism when their cellular density reaches a characteristic threshold [177-180, 182]. 
Bacteria use QS to promote processes such as bioluminescence, the formation of biofilms and 
the expression of virulence-related genes [177-180, 182]. There are various signalling 
molecules used by bacteria to communicate among each other, but N-acyl homoserine 
lactones (AHLs) are the most studied and prevalent QS mediators [177-181, 183, 184]. 
Common AHLs contain a characteristic five-membered lactone ring in their core and are 
distinguished based on the identity of their alkyl chains (Fig. 4.2.). The length of the aliphatic 
chain is a determining factor for the substrate preference of enzymes that are capable of 
inactivating AHLs [177-181, 183, 184]. 
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Figure 4.1. Metallo-β-lactamase fold and active site geometries. In (A) the overall structure of the B3 MBL AIM-1 from P. aeruginosa (top; PDB: 
4AWY) displaying the αβ/βα fold characteristic to the MBL protein family, and the corresponding active site structure (bottom) are shown. The zinc 
ions are represented as grey spheres, (B)-(E): The active sites of AiiB (2R2D), GLXII from A. thaliana (2Q4D), MIM-1 and MIM-2, respectively, are 
shown for comparison. The residues are depicted as sticks, the water molecules as red spheres, the zinc and iron ions as grey and orange spheres. The 
residues are numbered according to individual protein amino acid sequences as well as the MBL numbering scheme (in bracket). 
 
 
 
 
 
E 
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Figure 4.2. Substrates (A), (C) and reaction mechanisms (B). Core structures of the substrates used and the mechanism of action of metallo--
lactamaeses and N-acyl homoserine lactonases. 
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Two distinct enzymatic mechanisms are known to inactivate AHLs, one involving the 
hydrolysis of the lactone ring, catalysed by AHLases, and the other one using AHL acylases 
to hydrolyse the amide bond of the substrate [178, 180, 181, 184]. Only AHLases have the 
characteristic MBL fold and contain a di-metallic center in their active site; the reaction 
catalysed by these enzymes resembles that of MBLs and involves ring opening (Fig. 4.2 B) 
[177, 180].  
In Chapter 3 I focused on the “MBL-like” properties of MIM-1 from Novosphingobium 
pentaromativorans and MIM-2 from Simiduia agarivorans [91, 92]. Both enzymes are Zn(II)-
dependent and have a preference for β-lactam substrates from the penam group (e.g. penicillin 
G, ampicillin). Interestingly, while catalytic activity could be reconstituted with other divalent 
metal ions the substrate preference was affected by the identity of the metal ion. For example, 
while penams are the preferred substrate for the Zn(II) derivative of both MIM-1 and MIM-2 
their Cu(II) derivatives displayed no measurable activity towards these reactants. In contrast, 
the reactivity towards biapenem, a β-lactam substrate from the carbapenem group, is only 
mildly reduced for MIM-1 and significantly enhanced for MIM-2 upon the replacement of 
Zn(II) by Cu(II) [92]. Furthermore, modest activity could also be reconstituted for most 
substrates tested in the presence of Ca(II), not a metal ion commonly found in the active sites 
of metallohydrolases. Neither N. pentaromativorans nor S. agarivorans are known pathogens. 
While it cannot be ruled out that these organisms may have evolved MBL-like enzymes due 
to antibiotic pollution in their habitats, it is possible that the biologically relevant substrate(s) 
and thus the corresponding in vivo functions of MIM-1 and MIM-2 are unrelated to their in 
vitro MBL activity. In this Chapter the plasticity of the MBL fold will be investigated. 
Bioinformatics tools as well as kinetic assays were used to highlight the functional 
promiscuity of MIM-1 and MIM-2 and their ability to operate as bi-functional enzymes. The 
outcomes discussed in this Chapter may be of relevance for medicinal chemistry as they 
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demonstrate that some promiscuous enzymes may have the capability to link the inactivation 
of chemotherapeutics (i.e. antibiotics) to processes such as QS (and in particular its 
association with biofilm formation), thus compounding the challenge associated with 
antibiotic resistance.  
 
4.2 Materials and methods  
4.2.1 Materials  
The sequences encoding MIM-1 and MIM-2 were cloned into the commercial vector pJ411 
(DNA 2.0). All chemicals were of analytical grade. Escherichia coli BL21 (DE3) pLysS cells 
(Agilent) were used for recombinant expression of the proteins. All chemicals were purchased 
from Sigma-Aldrich unless stated otherwise.  
 
4.2.2 Database search, sequence alignments and phylogenetic analysis  
A BLAST search (http://blast.ncbi.nlm.nih.gov/Blast.cgi), using the amino acid sequences of 
MIM-1 and MIM-2 as templates, was used to identify homologs of these enzymes. The search 
was conducted within the non-redundant protein database. Proteins of interest were compared 
in a multiple sequence alignment using the free software Jalview2 on the Muscle server [185-
188]; the alignment was edited using ESPript 3.0 
(http://espript.ibcp.fr/ESPript/ESPript/index.php) [189]. The phylogenetic analysis was 
carried out using the MEGA 6 software package [190]. The phylogenetic tree was built using 
the Maximum Likelihood model (1000 iterations were used to test the goodness of the 
analysis). The tree was then edited using the software FigTree, available online 
(http://tree.bio.ed.ac.uk/software/figtree/).  
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4.2.3 Structural homology modelling and docking  
The protein sequences of both MIM-1 and MIM-2 were used to build homology structural 
models using the comparative structural building tool MODELER in the EasyModeller v4.0 
graphical environment [191].  
The models were built using the structure of the MBL AIM-1 from Pseudomonas aeruginosa 
as template (PDB: 4AWY; [138]). The structural alignments were conducted using the Swiss 
PDB Viewer software (http:// spdbv.vital-it.ch), using the annotated MBL structures of AIM-
1 and L1 from Stenotrophomonas maltophilia (PDB: 2FM6 for the native form; 2FU8 for the 
inhibitor (D-captopril)-bound form [192]), the AHLase AiiA from Bacillus thuringensis 
(PDB: 2A7M for the native form [193]; 3DHA and 3DHB for the complex with the substrate 
C6-HSL [194, 195]), and GLX-II from both Homo sapiens (PDB: 1QH3; [196]) and 
Arabidopsis thaliana (PDB: 2Q42; [197]). The root mean square (rms) deviations for 
structural superimpositions were obtained using the free software SuperPose [198]. The 
images were edited using the software PyMOL and USCF Chimera 1.9 
(http://www.cgl.ucsf.edu/chimera) [199]. The structure of the inhibitor D-captopril was 
generated using the software Avogadro. This inhibitor was then docked into the active sites of 
the MIM-1 and MIM-2 models using AUTODOCK 4.0 [200].  
 
4.2.4 Protein expression and purification 
The protocols for the expression and purification of recombinant MIM-1 and MIM-2 were 
previously optimized [92]. In brief, following expression the soluble fraction of the cell lysate 
was loaded onto a HiTrap Q FF 5 mL column (GE Healthcare). The enzymes were eluted 
with a NaCl gradient and loaded onto a HiPrep 16/60 Sephacryl S-200 HR column (GE 
Healthcare). Fractions containing MBL activity were pooled and stored at 4 °C in 50 mM 
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Hepes (pH 7.5) containing 0.2 M NaCl and 0.15 mM ZnCl2. The protein concentrations were 
estimated using theoretical extinction coefficients (ε280 = 36,815 M
− 1 cm− 1 for MIM-1 and 
41,285 M−1 cm−1 for MIM-2), calculated using the ProtParam tool 
(http://web.expasy.org/protparam/). Metal ion derivatives of MIM-1 and MIM-2 were 
prepared as described elsewhere [92].  
 
4.2.5 Enzymatic assays and data analysis  
The MBL activity of MIM-1 and MIM-2 was reported previously [92]. Here, the activity of 
these enzymes towards various AHLs and S-lactoylglutathione, a GLX-II substrate, was 
assessed. In order to increase the solubility of the AHL substrates solvents such as methanol 
need to be added into the assay mixture. Thus, in initial assays the sensitivity of MIM-1 and 
MIM-2 towards methanol was tested by following the MBL activity of the enzymes as a 
function of the solvent concentration. Meropenem was used as the substrate. The assays were 
carried out in 50 mM HEPES buffer, pH 7.5, 10 mM NaCl, with an enzyme concentration of 
15 nM.  
The AHLase activity assay employed a protocol previously described for enzymes such as 
carbonic anhydrase or haloalkane dehalogenase [201-206], and follows AHL hydrolysis by 
measuring the protons released during the reaction. The increase in the proton concentration is 
evaluated spectrophotometrically using an appropriate pH indicator. Here, we used Phenol 
Red in HEPES buffer to investigate the reaction between pH 7.4 and 7.6. The assay was 
recorded at 25 °C and 557 nm using 100–150 nM of enzyme in 1 mM HEPES, pH 7.5, 0.1 M 
NaCl2 and 0.2 mM Phenol Red. After incubation of this mixture for 2 min the reaction was 
initiated by adding substrate. For each substrate concentration the rate of the non-enzymatic 
AHL hydrolysis (i.e. autohydrolysis) was subtracted from that of the enzyme-catalysed 
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reaction. The net rate (i.e. the absorbance change (ΔAbs) per second) was then plotted against 
the substrate concentration fitted to the Michaelis–Menten equation to obtain relevant 
catalytic parameters (Vmax and Km). The Vmax value was used to calculate the 
corresponding kcat value using Eq. 6:  
 
        (6) 
 
In Eq. 6 [Enz]T is the total enzyme concentration in the assay and the value of θ is obtained 
experimentally by titrating a Phenol Red solution in HEPES buffer with a standard solution of 
HCl 0.1 M. The assay was typically conducted using the same Phenol Red concentration used 
in the enzymatic assay. The HCl dependency was studied using a 10 mM stock solution of 
HCl. In our measurements the value of θ was 0.003 Abs units/μM.  
Glyoxylase activity was measured using S-lactoylglutathione (SLG; 10 mM stock solution) in 
a 1 mL cuvette containing 20 mM 3-(N-morpholino)propanesulfonic acid (MOPS), pH 7.4. 
Both a continuous assay (at 240 nm) and a coupled one were employed to detect activity. In 
the coupled assay the hydrolysis of SLG was monitored by adding 20 μM 5,5′-dithiobis-2-
nitrobenzoate (DTNB), and following the increase in absorbance at 412 nm. When SLG is 
hydrolysed by GLX-II activity it releases D-lactic acid and reduced glutathione, which 
reduces DTNB to the yellow product 5-thio-2-nitrobenzoic acid (TNB) [206].  
Metal ion derivatives of MIM-1 and MIM-2 were also assayed as described above. The assay 
mixtures were supplemented with 50 μM of the respective divalent metal ion (i.e. Co(II), 
Mn(II), Cu(II) or Ca(II)). Negative controls containing only 50 μM metals ions in the reaction 
mixture were carried out to confirm that the substrates are not hydrolysed in the absence of 
enzymes. 
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4.3 Results and discussion  
4.3.1 Sequence and phylogenetic analysis  
MIM-1 and MIM-2 were initially identified in a homology database search using the MBL 
AIM-1 as probe [91] (see Chapter 2 for more details). This MBL shares approximately 50% 
sequence identity with MIM-1 and MIM-2 and all the amino acid residues that are involved in 
binding the two essential Zn(II) ions in the active site are invariant in each of the three 
proteins (Fig. 4.3.). It was thus plausible to assume that MIM-1 and MIM-2 may act as 
MBLs. Indeed, catalytic assays with a range of β-lactam substrates (Fig. 1.3.) demonstrated 
that both enzymes are potent MBLs in vitro [92] (see Chapter 3 for further details). In an 
attempt to address possible alternative biological roles the sequence database was searched 
using both MIM-1 and MIM-2 as probes. 
Not surprisingly, the closest homologs retrieved were MBLs (data not shown). These were 
followed by glyoxalase II (GLX-II; [206]) from A. thaliana (~45% similarity) and several 
AHLases including AttM [214-216] from Azhorizobium caulinodans and AhlK [212] from 
Klebsiella pneumoniae, with up to ~40% sequence similarity to both MIM-1 and MIM-2 
(Table 4.1.). As mentioned above AHLases play an intricate role in the QS network while 
GLX-II is involved in detoxification pathways. Known structures of GLX-II and AHLase 
indicate that they possess the αβ/βα fold characteristic of MBLs and can also accommodate 
two metal ions in their active sites (Fig. 4.1.). Although the overall sequence identity between 
MIM-1 and MIM-2 and GLX-II and various AHLases is, by and large, below 30%, essential 
amino acids are well conserved as illustrated in the multiple sequence alignment in Fig.4.3. 
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Figure 4.3. Multiple Sequence Alignment of B3 MBLs with AHL representatives 
(previous page). The sequences of AIM-1, MIM-1 and MIM-2 are aligned with N-acyl 
homoserine lactone representatives, AiiA from Bacillus sp. (240B1 [207] ), AidC from 
Chryseobacterium sp. StRB126 [208], AiiB from A. tumefaciens  [205], MomL from 
Muricauda olearia [209], AttM-Af from Agrobacterium fabrum str. C58 [210] , AhlK from 
Klebsiella pneumonia [211], AhlD from Arthrobacter sp. IBN110 [212] , QlcA from 
uncultured bacterium [213] . Above the alignment, secondary structure elements are drawn 
using AIM-1 as template. Highly conserved residues are highlighted in red; conserved regions 
are coloured in yellow. The residues involved in the metal binding are indicated by a black 
diamond; the residues known to be critical for lactonase activity and which are conserved in 
MIM-1 and MIM-2 are indicated by a grey star. Residue D115 is involved in metal binding 
and plays a critical role in lactone hydrolysis. The numbering scheme follows the canonical 
MBL numbering of AIM-1 (PDB: 4AWY) [138, 139]. 
 
The six residues involved in coordination of the two metal ions in the active site of AIM-1 
(i.e. His116, His118 and His196 for metal site 1 and Asp120, His121 and His263 for metal 
site 2, Fig. 4.1.) are invariant in MIM-1, MIM-2 and AHLases. In contrast to MBLs, but 
similar to the majority of binuclear metallohydrolases [2, 96, 138], AHLases and GLX-II have 
an aspartate ligand that bridges the two metal ions (Asp213 and Asp131 in Fig. 4.1. B and C, 
respectively). In GLX-II this bridging aspartate (i.e. Asp131) replaces one of the three 
histidine ligands but Site 2 is identical to that of AIM-1 and AHLases.  Both MIM-1 and 
MIM-2, like the majority of known MBLs [217], possess a putative signal peptide that may 
facilitate their transfer into the periplasmic space. The presence of such a signal peptide is not 
common among the currently known AHLases, with MomL from Muricauda olearia being 
the only exception [208]. In summary, the sequence comparison revealed that MIM-1 and 
MIM-2 are closer related to MBLs than AHLases or GLX-II as illustrated in a phylogenetic 
analysis (Fig. 4.4.).  
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Table 4.1. Sequence identities and similarities of AIM-1, MIM-1 and MIM-2 with 
representative AHLases and the GLX-II from A. thaliana (GLXII-At). The sequence 
similarity percentage was obtained using the PAM250 matrix available in the free web tool 
SIAS.  The following AHLases were used in the comparison: AiiA from Bacillus sp 240B1 
[218], AidC from Chryseobacterium sp. StRB126 [208], AttM from Agrobacterium 
tumefaciens [219], AiiB from Agrobacterium tumefaciens [205], MomL from Muricauda 
olearia [209],AttM from Agrobacterium fabrum [219], AhlK from Klebsiella pneumoniae 
[211], Attb from Agrobacterium fabrum [210], AhlD from Arthrobacter sp.IBN110 [212], 
QlcA from uncultured bacteria [213] and GLX-II from Arabidopsis thaliana [220]. 
 
Identity (%) Similarity (%) 
 
AIM-1 MIM-1 MIM-2 AIM-1 MIM-1 MIM-2 
AiiA 29% 29% 31% 39% 41% 39% 
AidC 30% 29% 31% 35% 37% 39% 
AttM-
At 
29% 30% 30% 40% 41% 40% 
AiiB-At 15% 16% 17% 38% 41% 40% 
MomL 25% 24% 29% 36% 36% 39% 
AttM 23% 23% 27% 32% 33% 34% 
AhlK 15% 16% 17% 39% 41% 41% 
AttB-
Af 
29% 30% 32% 37% 38% 38% 
AhlD 26% 29% 31% 35% 39% 40% 
QlcA 16% 18% 19% 25% 27% 28% 
GLXII-
At 
29% 28% 31% 39% 37% 39% 
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Figure 4.4. Phylogenetic analysis of MIM-1, MIM-2 and AHLs. The phylogenetic tree 
relates the B3 AIM-1, MIM-1 and MIM-2 with well-known AHLs. The analysis was 
conducted using the Neighbor-joining tree model, based on the amino acid sequences, using 
the software MUSCLE (2000 bootstrap replicates). Bootstrap coefficient below 50% are not 
shown. Scale bar, 0.9 amino acid substitution per amino acid position.  
 
4.3.2 Structural models of MIM-1 and MIM-2 
Crystals suitable for X-ray diffraction studies of MIM-1 and MIM-2 are currently not yet 
available. Hence, in the absence of experimental structural information homology models of 
the two proteins were generated using the crystal structure of their closest homolog, AIM-1 
(PDB: 4AWY), as template (Fig. 4.1.). The entire α carbon backbones of the MIM- 1 and 
MIM-2 models superimposed with rms values of 0.43 Å and 0.36 Å with the AIM-1 structure, 
respectively. The models are shown in Fig. 4.5. A similar approach using either a AHLase or 
GLX-II structure did not result in plausible models (data not shown). The most significant 
Chapter 4: Promiscuous metallo-β-lactamases: MIM-1 and MIM-2 may play an 
essential role in quorum sensing networks 
 
 
 
 
99 
deviations occur at the N-terminus, where only MIM-1 possesses an elongated tail which may 
be a reflection of its homo-dimeric nature, in contrast to MIM-2 and AIM-1, which are 
monomeric proteins [92]. In Fig. 4.1. the active sites of MIM-1 and MIM-2 are shown, each 
with two Zn(II) ions. The modelled water molecule (W) bridges the two metal ions and is 
believed to be the hydrolysis- initiating nucleophile in most MBLs [16, 18, 96].  
The main reason for generating homology models of MIM-1 and MIM-2 was to probe the 
possibility if their active sites are able to accommodate diverse substrates that may account 
for different biological functions. For calibration D-captopril was docked into the active sites 
of the two enzymes since a crystal structure of this molecule bound to the active site of the 
MBL L1 from S. maltophilia is known [192]. D-Captopril is a potent non-clinical, 
competitive inhibitor of MBLs with inhibition constants in the low micromolar range [16, 23, 
92, 96, 221].  
We have shown previously that this compound binds to MIM-1 and MIM-2 in a mode and 
with an affinity similar to that observed for MBLs; the recorded competitive inhibition 
constants (Kic values) are ~6 μM for both enzymes [92] (refer to Chapter 3 for details 
regarding the inhibition studies). In the models of MIM-1 and MIM-2 the best docking scores 
were obtained when D-captopril bound to the metal centers in a bidentate mode as shown in 
Fig. 4.6. A and Fig. 4.7. A. Although this best fit disagrees with the mode of binding 
observed in the crystal structure of the MBL L1 (where the thiol group of D-captopril bridges 
the two metal ions [192]) it is in good agreement with the computational data reported for the 
MBL BcII from Bacillus subtilis. In the next phase of modeling, since kinetic measurements 
indicated that penicillin G is the most efficient substrate for both MIM-1 and MIM-2 [92], this 
substrate was also docked into the active sites of these enzymes (Fig. 4.6. B and Fig. 4.7. B). 
While no comparison to experimental structures can be made for these substrate-bound 
complexes the positioning of the scissile β-lactam bond in the vicinity of the metal ion-
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bridging water molecule (see arrow in Fig. 4.6. B and Fig. 4.7. B) is in good agreement with 
currently accepted models for the reaction mechanism whereby the bridging water/hydroxide 
attacks the carbonyl carbon atom of the β-lactam ring to initiate ring opening [16, 18]. The 
docked mode of binding also resembles that observed for the complex of the MBL NDM-1 
with hydrolyzed ampicillin [77]. 
The docking studies provide some confidence that reasonable insight may be gained 
for enzyme–substrate interactions relevant to MIM-1 and MIM-2. Thus, the AHL substrate 
C6-L-HSL (Fig. 4.2. A) and S-(2-hydroxyacyl)lglutathione (Fig. 4.2. C) were also docked 
into the active sites of MIM-1 and MIM-2. Both enzymes bind the lactone in a similar 
fashion, with the two oxygen atoms of the lactone ring coordinating each to one of the metal 
ions in the active site (Figs 4.6. C and 4.7. C). This mode of binding is consistent with the 
structural complex of AiiA from B. thuringensis with hydrolyzed N-hexanoyl-L-homoserine 
lactone [194, 195]. No consistent binding modes were obtained when S-lactoylglutathione 
was docked into the active sites of these enzymes, irrespective of the protonation state of the 
substrates carboxyl group. Docking thus suggests that MIM-1 and MIM-2 may act as 
AHLases but not as glyoxylases.  
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Figure 4.5. MIM-1 and MIM-2 structural models. The homology model was built using 
AIM-1 (PDB: 4AWY) as template. Both MIM-1 (A) and MIM-2 (B) show the characteristic 
αβ/βα fold, common to the MBL superfamily. The loops believed to play a major role in the 
contact with the substrates are coloured in red; the zinc in the active sites are coloured in light 
grey (A) and grey (B).  In C and D are shown the amino acids involved in the metal binding 
and the active site cleft formation. The amino acids are drawn as ball and sticks, the zinc ions 
are depicted as grey spheres and the putative bridging water molecule present in the active site 
is shown as a red sphere. 
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Figure 4.6. MIM-1 structural model dockings. The figure shows the model of MIM-1 
docked with the D-captopril (A), with the penicillin G (B) and with N-hexanoyl homoserine 
lactone (C6-L-HSL) (C), using the software AUTODOCK 4.2. It is showing the detail of the 
active site, with the two zinc ions (grey spheres), the amino acids involved in the metal 
binding (represented as green ball and sticks) and the D-captopril (orange), penicillinG 
(cyano) and C6-L-HSL (magenta) interacting with the active site. The image was made using 
USCF Chimera 1.9. 
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Figure 4.7. MIM-2 structural model dockings. The figure shows the model of MIM-2 
docked with the D-captopril (A), with the penicillin G (B) and with N-hexanoyl homoserine 
lactone (C6-L-HSL) (C), using the software AUTODOCK 4.2. It is showing the detail of the 
active site, with the two zinc ions (grey spheres), the amino acids involved in the metal 
binding (represented as green ball and sticks) and the D-captopril (orange), penicillinG 
(cyano) and C6-L-HSL (magenta) interacting with the active site. The image was made using 
USCF Chimera 1.9. 
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4.3.3 N-acyl homoserine lactonase activities of MIM-1 and MIM-2.  
Both the sequence and homology model analysis have indicated that MIM-1 and MIM-2 may 
act primarily as MBLs, but the possibility of alternative functions, especially as AHLases, 
could not be ruled out conclusively. Thus, both GLX-II and AHLase activity were tested by 
using either S-D-lactoylglutathione or a range of acyl-homoserine lactones, respectively, as 
substrates. Consistent with the docking studies no GLX-II activity was measurable for either 
enzyme but both are efficient AHLases. Since the alkyl chains of the lactone substrates lower 
their solubility in an aqueous environment the effect of methanol on enzyme stability was 
initially tested by recording the MBL activity of MIM-1 and MIM-2 as a function of added 
methanol. MIM-1 activity was not significantly altered using methanol concentrations up to 
20% in the assay mixtures (Fig. 4.8.). In contrast, MIM-2 is less stable in the presence of this 
solvent, losing almost half its activity at a methanol concentration of 10% (Fig. 4.8.). Thus, 
the AHLase assays were conducted in the presence of 20% or 5% methanol in the reaction 
mixture for MIM-1 and MIM-2, respectively.  
MIM-1
0 100 200 300
0
50
100
150
200
Meropenem (mM)
k
c
a
t 
(s
-1
)
0
5%
10%
20%
MIM-2 
0 100 200 300 400
0
20
40
60
Meropenem (mM)
k
c
a
t 
(s
-1
)
0
5%
10%
 
Figure 4.8. Methanol Inhibition of MIM-1 (left panel) and MIM-2 (right panel). The 
inhibition by methanol was tested following the hydrolysis of meropenem.  
 
The alkyl chain lengths for the various N-acyl homoserine lactone substrates tested ranged 
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from C4 to C12 (Fig. 4.2 A). Data were measured using the native Zn(II)-bound forms of 
MIM-1 and MIM-2, as well as several metal ion derivatives including Co(II), Cu(II), Mn(II) 
and Ca(II). In Fig. 4.9. and Fig. 4.10 experimental data for the various derivatives of MIM-1 
and MIM-2 are shown for the reaction with the HSL substrate.  
Relevant kinetic parameters (i.e. kcat, Km and kcat/Km) are listed in Tables 4.2 and 
4.3. For the Zn(II)-derivatives of MIM-1 and MIM-2 kcat values range between ~0.5 s
−1 to 
~3.5 s−1, and ~0.5 s−1 to ~8 s−1, respectively, without an apparent trend connected to the 
length of the alkyl chain (Table 4.2.). Similarly, the corresponding Km values do not appear 
to be directly linked to the alkyl side chain, and values range from ~ 1 μM to ~ 200 μM. For 
both MIM-1 and MIM-2 the most efficiently hydrolysed AHL substrate is C10-3oxo-DL-
HSL, with kcat/Km values of 2.5 × 10
6 s−1/M and 8.0 × 105 s−1/M, respectively. By and 
large, the catalytic efficiency of MIM-1 and MIM-2 towards the various AHL substrates is 
favourable to that of well-established AHLases such as AiiA from Bacillus sp. 240B1, AiiB 
from A. tumefaciens or AidC from Chryseobacterium sp. StRB126 (Table 4.3.). The more 
recently discovered AHLase MomL from M. olearia [219] has higher kcat values than the 
remaining enzymes, but its affinity for the tested substrates is generally weaker than in MIM-
1 or MIM-2.  
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Figure 4.9. Kinetic parameters analysis of the N-acyl homoserine lactonase activities of 
MIM-1. Michaelis-Menten kinetic data for the Zn(II)- (circle), Co(II)- (square), Cu(II)- 
(triangle), Mn(II)- (inverted triangle) and Ca(II)- (diamond) substituted MIM-1 for the 
hydrolysis of various HSL substrates are shown. 
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Figure 4.10. Kinetic parameters analysis of the N-acyl homoserine lactonase activities of 
MIM-2. Michaelis-Menten data for the Zn(II)- (circle), Co(II)- (square), Cu(II)- (triangle), 
Mn(II)- (inverted triangle) and Ca(II)- (diamond) substituted MIM-2 for the hydrolysis of 
various HSL substrates are shown. 
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The catalytic data strongly suggest that MIM-1 and MIM-2 are bifunctional enzymes, with 
both being very efficient AHLases and MBLs. However, they are not the first AHLases that 
may display functional promiscuity. The enzymes SsoPox from Sulfolobus solfataricus [222] 
and OPH from Rhodococcus erythropolis and R. ruber [223] were initially identified as 
organophosphate (OP)-degrading hydrolases, but both possess AHLase activity as well 
(Table 4.3.). 
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Table 4.2 A. Comparison of the lactonase activities of metal ion-derivatives of MIM-1. The kinetic parameters of Zn(II)-, Co(II)-, Cu(II)-, Mn(II)- or 
Ca(II)-substituted MIM-1 are compared.  The activity assays were conducted in the presence of excess of M(II) and in the presence of different N-acyl 
homoserine lactones (Fig. 1B). 
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Table 4.2. Comparison of the lactonase activities of metal ion-derivatives of MIM-2. The kinetic parameters of Zn(II)-, Co(II)-, Cu(II)-, Mn(II)- or 
Ca(II)-substituted MIM-2 are compared.  The activity assays were conducted in the presence of excess of M(II) and in the presence of different N-acyl 
homoserine lactones (Fig. 1B). 
 
 
Table 4.3. Comparison of lactonase activities (next page). The kinetic parameters for the N-acyl homoserine lactonase activities found for MIM-1 and 
MIM-2, in the presence of different substrates, are compared with those reported for AiiB from Agrobacterium tumefaciens [205], AiiA from Bacillus sp 
240B1 [218], MomL from Muricauda olearia [209], AidC from Chryseobacterium sp. StRB126 [208], SsoPox from Sulfolobus solfataricus [222] and OPH 
from Brevundimonas diminuta [223].  
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AiiA[218] AiiB[205] AidC[208] 
Substrate kcat  (s-1) Km  (µM) kcat/Km(s-1/M) kcat  (s-1) Km  (µM) kcat/Km(s-1/M) kcat  (s-1) Km  (µM) kcat/Km(s-1/M) 
C12-30x0-DL-HSL NA NA NA NA NA NA NA NA NA 
C12-DL-HSL NA NA NA NA NA NA NA NA NA 
C10-3oxo-DL-HSL NA NA NA NA NA NA 1.97 ± 0.11 72 ± 5.3 2.7*104 
C10-DL-HSL NA NA NA 0.28 ± 0.08 110 ± 50 1.5*103 NA NA NA 
C8-3oxo-DL-HSL NA NA NA 3.7 ± 0.1 2.5 ± 0.3 (mM) 1.5*103 2.12 ± 0.24 64 ± 3.7 3,3*104 
C8-DL-HSL NA NA NA 10.3 ± 0.2 1.0 ± 0.1 (mM) 1.0*104 2.01 ± 0.31 64 ± 4.9 3,1*104 
C7-DL-HSL NA NA NA NA NA NA NA NA NA 
C6-3oxo-DL-HSL NA NA NA 11.0 ± 0.4 4.6 ± 0.5 (mM) 2.4*103 2.35 ± 0.29 46 ± 2.1 5.1*104 
C6-DL-HSL 91 ± 3 5.6 ± 0.6 (mM) 1.6*104 24.8 ± 0.9 1.6 ± 0.2 (mM) 1.6*104 2.31 ± 0.16 55.0 ± 4.3 4.2*104 
C4-DL-HSL NA NA NA 5.8 ± 0.3 15 ± 1 (mM) 3.9*102 NA NA NA 
 
 
MomL[209] SsoPox[222] OPH[223] 
Substrate kcat  (s-1) Km  (µM) kcat/Km(s-1/M) kcat  (s-1) Km  (µM) kcat/Km(s-1/M) kcat  (s-1) Km  (µM) kcat/Km(s-1/M) 
C12-30x0-DL-HSL NA NA NA 0.95 ± 0.03 170 ± 2 5.5*103 1.83 ± 0.05 101 ± 7 1.8*104 
C12-DL-HSL NA NA NA NA NA NA NA NA NA 
C10-3oxo-DL-HSL 224 ± 12 440 ± 100 5.1*105 1.5 ± 0.2 50 ± 0.1 3.0*105 2.67 ± 0.03 184 ± 4 1.4*104 
C10-DL-HSL NA NA NA NA NA NA NA NA NA 
C8-3oxo-DL-HSL 218 ± 14 490 ± 110 4.5*105 
   
4.66 ± 0.03 608 ± 8 7.6*103 
C8-DL-HSL 158 ± 17 440 ± 160 3.6*105 2.0 ± 0.3 93 ± 27 2.1*104 NA NA NA 
C7-DL-HSL NA NA NA NA NA NA NA NA NA 
C6-3oxo-DL-HSL 293 ± 17 950 ± 160 3.1*105 0.52 ± 0.05 5.6 ± 0.9 (mM) 18 ± 7 NA NA NA 
C6-DL-HSL 226 ± 8 790 ± 80 2.9*105 NA NA NA 3.17 ± 0.02 526 ± 9 6.3*103 
C4-DL-HSL 135 ± 5 850 ± 90 1.6*105 NA NA 5.5*103 2.62 ± 0.02 412 ± 6 6.3*103 
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Furthermore, OP-degrading activity has previously also been associated with the MBL 
structural fold; the enzyme methyl parathion hydrolase (MPH) from Pseudomonas sp. WBC-3 
has the overall fold characteristic of MBLs but it is a highly efficient OP hydrolase without 
any measurable MBL activity [153, 176]. Functional promiscuity is thus not unprecedented 
among metallohydrolases, further exemplified by the enzyme purple acid phosphatase, which 
may act as a phosphatase in some tissue types or organisms, but as a peroxidase elsewhere 
[169]. Changes in the metal ion composition in the active site may contribute to observed 
functional changes in that enzyme [224, 225]. Since we previously demonstrated that metal 
ion replacements lead to changes in the substrate preference of both MIM-1 and MIM-2 [92] 
we probed the effect of such replacements on the catalytic parameters of the AHLase activity 
of these two enzymes (Table 4.2.). The effects of these substitutions are more subtle than 
observed for the MBL activity of these enzymes. Each of the metal ions tested is capable of 
reconstituting AHLase activity, with Co(II) being the most effective metal ion for most 
substrates and Ca(II) the worst. Co(II) was also found to be the most effective metal ion for 
other AHLases, including AiiB from A. tumefaciens, AiiA from B. thuringensis and MomL 
from M. olearia [204, 208, 209, 218].  
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4.4 Conclusion. 
MIM-1 and MIM-2 are two enzymes that demonstrate the plasticity of the MBL fold, a fold 
that promotes a range of seemingly unrelated functions. For instance, the organophosphate 
pesticide-degrading MPH uses this fold but has no MBL activity [176]. Our study into 
possible biological functions of MIM-1 and MIM-2 was triggered by the observation that both 
enzymes are very efficient lactamases in vitro despite residing in organisms that are not likely 
to have been subjected to evolutionary pressures associated with the increasing use of β-
lactam-based antibiotics since World War II [92]. Indeed, at the primary sequence level the 
closest homologs of MIM-1 and MIM-2 are known MBLs associated with the pathogenic 
effect of antibiotic resistance (Fig. 4.1., 4.3., 4.4.), but considerable similarity was also 
apparent to other enzymes of the family of dinuclear metallohydrolases, in particular 
glyoxalases and AHLases (Table 4.1.). Structural models of MIM-1 and MIM-2 indicated 
that their active sites can accommodate two metal ions using ligands identical to those used 
by some MBLs such as AIM- 1, FEZ-1 or L1 [27, 138, 192], but these models did not provide 
conclusive information about preferred substrates, an outcome that was not surprising 
considering the structural plasticity of the MBL fold. However, kinetic measurements ruled 
out that MIM-1 and MIM-2 may act as glyoxalases. In contrast, both enzymes are very 
efficient AHLases with catalytic parameters rivalling or even exceeding those of well-
characterized lactonases (Table 4.3.). This bifunctional behaviour of MIM- 1 and MIM-2 is 
thus another illustration of the versatility of the MBL fold, but it also poses an interesting 
conundrum with respect to the biological function(s) of these enzymes – based on their in 
vitro catalytic efficiencies it is not evident if they act preferably as MBLs or AHLases. 
Insofar, MIM-1 and MIM-2 are different from known MBLs, for which generally only one 
preferred function is reported. Similarly, we are not aware of any studies linking AHLases to 
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MBL activity, nor their inhibition by established MBL inhibitors such as D-captopril [177, 
180]. Of interest was also the observation that the metal ion composition of MIM-1 and MIM-
2 affects only their substrate preference for their MBL but not their AHLase activity (Table 
4.2.). While the in vivo metal ion composition of these enzymes remains uncertain it is 
possible that they may alter their function as a consequence of the identity of the metal ions 
bound in their active sites. In this context, it is interesting that MIM-1 and MIM-2 are active 
in presence of Ca(II), the concentration of which may potentially be regulated by their host 
organisms. This question may only be addressed when more information about the cellular 
metabolism of N. pentaromativorans or S. agarivorans becomes available. However, 
irrespective of the role(s) of MIM-1 or MIM-2 in their host organisms these enzymes are 
attractive targets to investigate structural factors that dictate substrate preference and 
concomitant functions of enzymes that possess the versatile MBL fold. As an essential step 
towards gaining functional insight our group is currently optimizing protocols to obtain 
crystals of a quality sufficient for X- ray diffraction studies. Ultimately, MIM-1 and MIM-2 
may hold important clues about structural factors that may be exploited to develop potent 
inhibitors as leads for novel chemotherapeutics to combat antibiotic resistance. The link 
between antibiotic resistance and QS may also be of relevance in future drug development 
strategies – enzymes such as MIM-1 and MIM-2 may, in principle, be a threat to health care 
due to their strong potential to degrade commonly used antibiotics, but they are also capable 
of preventing biofilm formation due to their ability to cleave AHLs. Since biofilms are 
frequently associated with antibiotic resistance [132, 180] MIM-1 and MIM-2 are bifunctional 
enzymes that possess activities with opposing effects with respect to antibiotic resistance. The 
question to address in future studies is if these two activities may be controlled and/or 
modulated separately. 
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Chapter 5: Active site geometry and reaction 
mechanism of MIM-1 and MIM-2 
 
 
5.1 Introduction 
 
In the previous chapters the enzymatic properties of two novel MBL-like enzymes from 
environmental microorganisms, i.e. MIM-1 from N. pentaromativorans and MIM-2 from S. 
agarivorans, were discussed in detail. Specifically, the two enzymes were identified due to their 
sequence homology to MBLs from subgroup B3 (see Chapter 2) and their proficiency in 
hydrolysing a range of relevant β-lactam antibiotics (see Chapter 3). The reaction mechanism 
employed by MBLs has been studied extensively using a range of techniques from chemical 
kinetics and spectroscopy. Variations are observed when different substrates were employed, as 
illustrated by the effects of pH on enzyme catalysis (e.g. Fig. 3.5 in Chapter 3).  Furthermore, it has 
emerged that in some MBLs (e.g. the B1 representative NDM-1 and the B3-representative L1) the 
rate-limiting step in the reaction with the model substrate nitrocefin (Fig. 5.1) is the decay of an 
anionic tetrahedral reaction intermediate formed upon the nucleophilic attack, while in other MBLs 
(e.g. the B1 representative Bla2) no reaction intermediate is observed [120, 226, 227].  
Interestingly, the B3-representative AIM-1 appears to be capable of adopting two alternative 
mechanistic strategies, one where a reaction intermediate is observed and one where no 
intermediate is apparent [129]. In this chapter the reaction mechanism of MIM-1 and MIM-2 is 
probed using an approach similar to that described in the studies of NDM-1, L1, Bla2 and AIM-1. 
Specifically, the substrate nitrocefin was used to facilitate a direct comparison of catalytic 
parameters.  
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Figure 5.1. Nitrocefin core structure. Due to the presence of the dinitro phenol functional group 
this cephalosporin derivative has a characteristic yellow colour, facilitating a simple colourimetric 
assay to monitor catalysis. 
 
5.2 Materials and Methods 
 
5.2.1. Materials  
 All chemicals were of analytical grade.  E. coli BL21 (DE3) pLysS cells (Agilent) were 
used for recombinant expression of the proteins.  All chemicals were purchased from Sigma-
Aldrich unless stated otherwise. 
 
5.2.2. Protein expression and purification 
 The protocols for the expression and purification of recombinant MIM-1 and MIM-2 were 
previously described (see Chapter 3).  In brief, the expression of the recombinant enzymes was 
induced with 0.2 mM isopropyl β-D-1-thiogalactopyranoside (IPTG).  The cells were harvested 
by centrifugation and pellets were resuspended in ~20 mL of buffer containing 20 mM Tris (HCl; 
pH 7.0) and 0.15 mM ZnCl2.  The cells were then disrupted using five rounds of sonication (60% 
of the maximal output power for 30 seconds in each round).  The supernatant was loaded onto a 
HiTrap Q FF 5 mL column (GE Healthcare), pre-equilibrated with 20 mM Tris (HCl; pH 7.0) and 
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0.15 mM ZnCl2.  Proteins were eluted using a linear gradient from 0 to 0.5 M NaCl.  MIM-1 
eluted between 55 mM and 175 mM of NaCl, while MIM-2 eluted between 35 mM and 135 mM 
of NaCl.  Relevant fractions with MBL activity were pooled and loaded onto a HiPrep 16/60 
Sephacryl S-200 HR column (GE Healthcare), pre-equilibrated with 50 mM Hepes (pH 7.5), 
containing 0.2 M NaCl and 0.15 mM ZnCl2.  The purity of the protein samples was confirmed by 
SDS-PAGE analysis.  The protein concentrations were estimated using theoretical extinction 
coefficients (ε280 = 36,815 M-1cm-1 for MIM-1 and 41,285 M-1cm-1 for MIM-2), calculated using 
the ProtParam tool (http://web.expasy.org/protparam/).  
Metal ion derivatives of MIM-1 and MIM-2 were prepared as described in Chapters 3 and 4. 
 
5.2.3. Enzymatic assays and data analysis  
 
 Steady-state kinetic assays were conducted with the Zn(II)-, Co(II)- and Ca(II)-derivatives 
of MIM-1 and MIM-2, following the hydrolysis of the cephalosporin derivative nitrocefin (Fig. 5.1) 
at 390 nm. The substrate conversion rate was calculated using an extinction coefficient ε390 = 
11 500 M–1cm–1. All the measurements were conducted in 20 mM TRIS, pH 7.0, in the presence of 
[M(II)] = 200 μM (where M = Zn, Co or Ca), at 25° C with a Shimadzu UV-2550 
spectrophotometer, using a 1 cm path length quartz cuvette. The final protein concentration in the 
assays was 20 nM.  
 Stopped-flow measurements were carried out using an Applied Photophysics SXPRO-20 
spectrophotometer equipped with a photodiode array and fluorometer detector.  Absorbance and 
fluorescence measurements were performed with a final concentration of enzyme and substrate (i.e. 
nitrocefin) 30 μM and 20 μM, respectively.  The excitation and emission wavelengths used in the 
fluorescence experiments were 295 nm and 330 nm, respectively.  The wavelength range for the 
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absorbance measurements was from 300 nm to 700 nm.  The path lengths used were 1 cm or 0.2 cm 
for absorbance or fluorescence experiments, respectively, while the respective slit widths were 4 
mm and 2 mm. Reaction progress curves at 390 nm (i.e. substrate decay) and 485 nm (i.e. product 
formation) were generated from the diode array absorption measurements by converting the 
experimental data to concentration values using the following respective extinction coefficients: 
11 500 M–1cm–1 and 17 400 M–1cm–1 [228, 229]. Rate constants kobs for substrate decay and product 
formation were obtained by fitting the data to first-order exponentials of the following form 
(Equation 5.1):  
 
           Eq. 5.1 
 
where [M]t and [M]0 represent the concentration of the substrate or the product at time t or at the 
beginning of the reaction, respectively; b is a fitting parameter and t is the time in seconds.  
The data were also modelled using FITSIM software in order to obtain an estimate of individual 
microscopic rate constants [120, 230, 231]. The model used to fit the experimental data is shown in 
Fig. 5.2 and assumes reversibility (characterised by forward and reverse rate constants) at every 
step of the reaction. A similar model was previously employed to characterise the catalytic turnover 
of Bla2 and AIM-1 [120, 129]. 
 
 
Figure 5.2. Schematic representation of the catalytic mechanism for the reaction of MIM-1 
and MIM-2 with the -lactam substrate nitrocefin. The model assumes three fully reversible 
steps for the mechanism.  
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5.2.5. Magnetic circular dichroism  
 
The Co(II)-derivatives of MIM-1 and MIM-2 were dissolved in a 60%/40% (v/v) mixture of 
glycerol/buffer (20 mM TRIS, pH 7.0) and filled in a 0.62 cm path length nickel-plated copper 
sample cell with quartz windows. The MCD system used a JASCO J815 spectropolarimeter and an 
Oxford Instruments SM4000 cryostat/magnet. Data were collected at increments of 0.5 Tesla (T) 
from 0 to 7.0 T and at a temperature of 1.4 K. Each spectrum was corrected for any natural CD by 
subtracting the zero-field spectrum of the sample. Even when there is no sample present the 
instrument baseline exhibits a small deviation from zero that is both field- and wavelength-
dependent [232]. Therefore, each spectrum was also corrected by subtraction of a spectrum 
recorded at the same magnetic field but with no sample present. The resultant spectra were fitted to 
the minimum number of Gaussian peaks to achieve a satisfactory composite spectrum using the 
GRAMS AI software and analysed as described elsewhere [232]. 
 
5.2.6. Electron paramagnetic resonance  
 
 Low-temperature EPR spectra were obtained on a Bruker Elexsys EMX EPR spectrometer 
equipped with an Oxford Instruments ESR900 liquid helium flow cryostat. The spectra were 
recorded at 9.64 GHz (B0⊥B1) or 9.38 GHz (B0∥B1) using a Bruker DM4116 dual-mode cavity, with 
10 G (1 mT) magnetic field modulation (100 kHz), with a constant/conversion time of 42 ms and a 
receiver gain at 1 × 104.  Spin Hamiltonian parameters were estimated from computer simulations 
carried out using XSophe (Bruker Biospin), assuming H0 = βB0gŜ/ħ+ ŜDŜ, where S = 3/2, D >> 
βgBS/ħ, and where D > 0 implies the MS = ±1/2 Kramers doublet lies lowest and all observed EPR 
transitions are from this doublet, and D < 0 implies the MS = ±3/2 Kramers doublet lie lowest and 
all observed EPR transitions are from this doublet.  
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5.2.7. 1H Paramagnetic NMR 
 
1H NMR spectra were collected on a Bruker Avance 500 spectrometer operating at 500.13 MHz, 
298 K, magnetic field of 11.7 T, recycle delay (AQ) of 41 ms, and sweep width of 400 ppm. Proton 
chemical shifts were calibrated by assigning the H2O signal the value of 4.70 ppm. A modified pre-
saturation pulse sequence was used to suppress the proton signals originating from solvent. The 
presaturation pulse was as short as possible (500 ms) to avoid saturation of solvent-exchangeable 
proton signals. The concentration of NMR samples was generally in the range of 1.0-1.2 mM. 
Samples in D2O were prepared by performing three or more dilution/concentration cycles in a 
Centricon-10 column. 
 
5.3. Results and Discussion 
 
5.3.2 Characterisation of the steady-state catalytic parameters for the hydrolysis of nitrocefin 
 
In order to compare catalytic parameters of MIM-1 and MIM-2 with corresponding parameters 
from well-known MBLs (e.g. AIM-1, NDM-1 [128] and Bla2 [120]) the steady-state parameters 
for the turnover of the substrate nitrocefin needed to be established.  Relevant experimental data 
and catalytic parameters for the Zn(II)-, Co(II)- and Ca(II)-derivatives of both enzymes are shown 
in Fig. 5.3 and Table 5.1.  
For both enzymes and every metal ion derivative tested the data reveal Michaelis-Menten-type 
saturation behaviour; no substrate inhibition as observed with other substrates (see Chapter 3) was 
evident.  This indicates that nitrocefin only has one binding site in the vicinity of the active centre, 
possibly preventing binding of a second substrate molecule to an inhibitory site due to its large size 
(compare Figs 5.1 and Fig. 1.3). Interestingly, nitrocefin appears to bind with similar affinity to 
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both enzymes, irrespective of the metal ion composition, based on the relatively conserved Km 
values (ranging from ~40 to ~70 μM).   
 
Table 5.2. Kinetic parameter obtained for MIM-1 and MIM-2 for the hydrolysis of nitrocefin 
in the presence of Zn(II), Co(II) and Ca(II). 
 MIM-1 MIM-2 
 kcat (s-1) Km (µM) kcat/Km (s-1/M) kcat (s-1) Km (µM) kcat/Km(s-1/M) 
Zn(II) 899 ± 53 73 ± 10 1.2*107 1073 ± 48 49 ± 6 2.1*107 
Co(II) 57 ± 2 64 ± 6 8.9*105 12 ± 0.5 47 ± 5 2.5*105 
Ca(II) 3 ± 0.1 44 ± 6 6.8*104 17 ± 0.7 48 ± 6 3.4*105 
 
However, great variations are observed with respect to the kcat when different metal ion derivatives 
are compared (Table 5.1).  With a kcat in the range of ~1000 s-1 for both native, Zn(II)-containing 
enzymes nitrocefin is turned over considerably faster than other cephalosporin substrates (i.e. 
cefuroxime and cefoxitin; see Table 3.2 in Chapter 3).  However, the Co(II)- and Ca(II)-derivatives 
are far less reactive than their Zn(II)-counterparts; indeed, nitrocefin is turned over at a rate similar 
to that recorded for other cephalosporin substrates.  Thus, while metal ion replacements do not 
appear to affect substrate binding significantly, they have a profound influence on the catalytic steps 
that follow initial substrate binding.  In order to shed light into those steps the reactions were 
probed under single turnover conditions using stopped-flow techniques. 
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Figure 5.3. Rate vs [nitrocefin] profiles of metal ion derivatives of MIM-1 and MIM-2. The 
data were analysed by fits to the Michaelis-Menten equation as described in Chapter 3.  
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5.3.3 Rapid single-turnover kinetics experiments 
 
The hydrolysis of nitrocefin by metal ion derivatives of MIM-1 and MIM-2 was recorded 
with a photodiode array detector in the range between 300 and 700 nm (Figure 5.4) and shows the 
disappearance of the substrate at 390 nm and the emergence of the ring-opened product at 485 nm. 
For each derivative the reaction is completed after ~0.6 ms. In Figure 5.5 the time courses of the 
concentration change for the substrate and product are shown. It should be pointed out that only in 
the case of the Co(II)- and Ca(II)-derivatives of MIM-1 and MIM-2 an intermediate was 
observable, however at insignificant concentrations and with an half-life not consistent with the 
substrate depletion. This could indicate that, in the presence of different metal ions the proteins 
hydrolyse the substrate through a different mechanism, exploiting the acyl-enzyme intermediate 
observed in the case of other well-known MBLs [120]. However, further investigation is needed to 
support this hypothesis.  This observation indicates that MIM-1 and MIM-2 are likely to operate 
like the MBLs Bla2 and AIM-1, but different to NDM-1 or L1 (where a reaction intermediate was 
observable; see Section 5.1).  
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Figure 5.4. Stopped-flow spectroscopy of the Zn(II)-, Co(II)- and Ca(II)-derivatives of MIM-1 
and MIM-2. The hydrolysis of 30 µM nitrocefin by 20 µM MIM-1 and MIM-2 was followed in 20 
mM TRIS, pH 7.0, at 25 °C. Absorbance spectra from 300 to 775 nm were recorded ~1.28 ms after 
mixing (deadtime of the instrument). The reaction was complete after ~0.6 s. The absorbance 
decreased at 390 nm (substrate), and increased at 485 nm (product). 
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Figure 5.5. Time course of concentration changes in single turnover experiments with 
MIM-1 and MIM-2. Concentrations for substrate (circle void dots) and product (square void 
dots). The absorbances were converted to concentration units as described in Materials and 
Methods. The experimental data were fitted to a first-order exponential. The fitted lines are 
shown as blue (substrate) and red (product) lines. 
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The data in Fig. 5.5 were analysed by fitting the time course of substrate decay and product 
formation to an exponential (Eq. 5.1), resulting in first-order rate constants kobs (Table 5.2).  
For both enzymes, independent of their metal ion composition, similar kobs values in the order 
of ~5 - 8 s-1 were recorded.  
 
Table 5.2. Estimated first-order rate constants (s-1) obtained for the Zn(II)-, Co(II)- and 
Ca(II)-derivatives of MIM-1 and MIM-2 for the hydrolysis of nitrocefin.  
 
MIM-1 MIM-2 
 
kobs (s-1) kobs (s-1) 
 
Substrate (390 nm) Product (485 nm) Substrate (390 nm) Product (485 nm) 
Zn(II) 6.6 ± 0.1 6.9 ± 0.1 4.9 ± 0.1 5.0 ± 0.1 
Co(II) 4.3 ± 0.1 5.5 ± 0.1 4.2 ± 0.1 5.4 ± 0.1 
Ca(II) 6.2 ± 0.1 7.5 ± 0.1 4.5 ± 0.1 8.3 ± 0.1 
 
 
 
Figure 5.6. Schematic representation of a possible catalytic mechanism for the reaction 
of MIM-1 and MIM-2 with the -lactam substrate nitrocefin.  
 
The data pose a significant conundrum in the interpretation of the mechanism.  In the single 
turnover experiments product is formed at a rate of ~5 s-1 while the kcat measured under 
steady-state conditions (see Fig. 5.3 and Table 5.1), in particular for the native Zn(II)-
derivatives of MIM-1 and MIM-2, are in the order of ~1000 s-1.  It needs to be pointed out 
that while both the steady-state and single turnover experiments measure the same process  
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(i.e. the emergence of hydrolysed nitrocefin) differences might be expected if the regeneration 
of the active site for the next catalytic cycle requires the presence of substrate.  In other 
words, in a single turnover experiment the release of product from the EP complex (Fig. 5.6) 
might be slow but in the presence of excess substrate the product gets easily displaced by this 
reactant due to its higher affinity.  This would imply that substrate binding is rather rapid but 
that the regeneration of the active site to its resting state might be considerably slower as, 
ultimately, in the final catalytic cycle no substrate remains available to promote product 
expulsion. 
 In an attempt to probe this hypothesis the stopped-flow single turnover experiments 
were carried out in fluorescence mode (Fig. 5.7). The underlying idea behind this approach is 
that MBLs have a conserved tryptophan residue (i.e. Trp93 in NDM-1, Trp38 in L1 and 
Trp38 in AIM-1) [129] in the vicinity of the active site. Its perturbation, promoted by the 
binding of the substrate, is anticipated to result in changes in the intrinsic fluorescence 
properties of the enzymes. Indeed, stopped-flow fluorescence measurements with NDM-1, L1 
and AIM-1 have demonstrated that their interaction with the substrate nitrocefin leads to an 
initial rapid quench in fluorescence, followed by a slower regain [129, 143, 227]. In MIM-1 
and MIM-2 the corresponding tryptophan residue is also conserved (Trp86 and Trp33, 
respectively).  For each metal ion derivative of both enzymes a very rapid quench in 
fluorescence is observed, followed by a slower regain, thus matching the behaviour reported 
for other MBLs (Fig. 5.7).  The rate of the fluorescence decay could not be accurately 
estimated as the process was complete close to the dead time of the instrument (thus, a rate 
exceeding 500 s-1 is a reasonable estimate).  In contrast, reliable estimates for the rate 
constants for the fluorescence regain could be obtained from fitting the experimental data to 
single exponential functions.  Relevant parameters are listed in Table 5.3.  Interestingly, these 
rates are in reasonable agreement with the rates of product formation recorded in single 
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turnover experiments (see above). The rates, for all the metal derivatives both for MIM-1 and 
MIM-2, are in the order of ~5 s-1, in agreement with the observed rates for NDM-1 and L-1 
but in contrast to what has been recently observed for AIM-1, in which the regain in 
fluorescence is greater by one order of magnitude [129]. 
 
 
Figure 5.7. Fluorescence progression curve for MIM-1 (left) and MIM-2 (right) at 280 
nm. The Figure shows the experimental data points for the Zn(II) (void squares), Co(II) (void 
triangles) and Ca(II) (void inverted triangles) derivatives. The experimental data points were 
fitted to a first-order exponential and the resulting fits are shown as blue (for the Zn(II)), red 
(for the Co(II)) and green (for the Ca(II)). 
 
Table 5.3. Estimated first-order rate constants (s-1) obtained for MIM-1 and MIM-2, in 
the presence of Zn(II), Co(II) and Ca(II), during the hydrolysis of nitrocefin, followed by 
fluorescence measurements. 
MIM-1 MIM-2 
kobs (s-1) kobs (s-1) 
Zn(II) Co(II) Ca(II) Zn(II) Co(II) Ca(II) 
2.1 ± 0.1 1.4 ± 0.3 4.2 ± 0.5 2.6 ± 0.1 2.6 ± 0.2 7.1 ± 0.3 
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In summary, the combined kinetic data provide insight into how metal ions may 
influence the catalytic turnover. It was already demonstrated in Chapter 3 that a change in the 
metal ion composition may affect the substrate specificity of both MIM-1 and MIM-2 (see 
Table 3.6), an observation that suggested that different metal ions may lead to subtle 
conformational (i.e. structural) variations that affect substrate binding.  Here, it was 
demonstrated that the mechanism of a single catalytic turnover may be conserved, 
independent of the metal ion composition (Figs 5.3 – 5.7).  However, with respect to the 
steady-state rate constant measured under pseudo-first order conditions there is a great 
difference between the three metal ion derivatives tested (Fig. 5.2 and Table 5.1).  Zn(II), the 
native metal ion, is by far the most efficient promoter of catalysis, likely due to the increased 
lability of the enzyme-product complex in the presence of this metal ion.  This interpretation 
opens a novel, not previously recognised possibility for the design of a strategy to combat 
antibiotic resistance.  If it was possible to develop antibiotics that, albeit hydrolysed, remain 
tightly bound to the metal centre, they may inactivate the enzymes sufficiently to have a 
significant detrimental effect on pathogenic virulence. 
Extensive kinetic data for different metal ion derivatives as described in this Chapter 
are currently not available for other MBLs.  Hence, it is not yet possible to generalise the 
above hypothesis.  But based on the similarities of available catalytic parameters (as described 
in Chapters 3 and 5) it appears likely that the active sites of MIM-1 and MIM-2 share 
extensive homology with those of other MBLs.  In order to substantiate this assumption 
spectroscopic studies were carried out, using the Co(II)-derivatives of both MIM-1 and MIM-
2.  Co(II) was used as it is a suitable spectroscopic probe for methods such as electron 
paramagnetic resonance (EPR) and magnetic circular dichroism (MCD).  Furthermore, 
comparable data are available for a range of MBLs, including NDM-1, L1, Bla2 and AIM-1 
[120, 129, 227, 229]. 
Chapter 5: Active site geometry and reaction mechanism of MIM-1 and MIM-2 
 
 
 
 
130 
5.3.3. Spectroscopic characterization of the active site structures of MIM-1 and MIM-2 
 
 MCD has been demonstrated to be a useful probe for the active site geometry and the 
reaction mechanism of a range of binuclear metallohydrolases, including aminopeptidases, 
organophosphate-degrading enzymes and corresponding biomimetic complexes [11, 24, 25, 
97, 172, 174, 232, 233].  Recently, this method was also applied to study the active site of the 
MBL AIM-1 [129].  Corresponding data were collected for the Co(II)-derivatives of MIM-1 
and MIM-2 (Fig. 5.8).  For MIM-1, in the resting state, the MCD spectrum could be fit to no 
fewer than five transitions between ~460 and ~560 nm.  These d-d transitions are very similar 
to those observed for AIM-1 and were thus assigned to two six-coordinate Co(II) species 
[129].  Similarly, the spectrum of resting MIM-2 could be resolved into a minimum of five 
transitions, although they were shifted to higher energy (spanning ~420 to 520 nm).  While it 
is currently unknown why there is a stronger ligand effect on the d orbital splitting in MIM-2 
when compared to MIM-1 and AIM-1, this observation is indicative of structural variations 
between these enzymes (e.g. differences in bond lengths and angles, etc).  However, common 
to all three enzymes is that there are two six-coordinate Co(II) ions in the active site. 
Importantly, the addition of the inhibitor D-captopril did not affect the position of the 
transitions in either sample, again in agreement with a similar observation recently reported 
for AIM-1 [129].  Considering the relatively tight binding of this inhibitor to both MIM-1 and 
MIM-2 (see Chapter 3) and also available crystal structures that show D-captopril bound to 
the metal centres of the MBLs L1 and AIM-1 the lack of any spectral changes was surprising 
[129, 192]. 
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Figure 5.8. MCD spectra of MIM-1 (A) and MIM-2 (B). Data were measured at 7 T and 
1.4 K in the absence and presence of the inhibitor D-captopril.  The raw spectral data were 
resolved into individual transitions by fitting the minimum number of Gaussians. 
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However, in AIM-1 the crystal structure of the AIM-1-D-captopril complex indicates 
that the thiol group of the inhibitor displaces the bridging water molecule, thus coordinating 
to both metal ions.  Nonetheless, corresponding MCD data did not reveal significant spectral 
changes.  This was interpreted in terms of D-captopril (i) either not binding to the metal ions 
at all in solution (in contrast to the solid state arrangement), or (ii) coordinating via its 
carboxyl group to one or both metal ions, a coordination ligand and mode that would be 
expected to have a considerably weaker effect on the ligand field than a thiol group.  The 
same interpretation thus appears plausible for MIM-1 and MIM-2. 
The electronic structure and in particular the effect of D-captopril binding was also 
investigated by paramagnetic 1H NMR spectroscopy. The spectra acquired for MIM-1 and 
MIM-2 do not show any of the complexity reported for other well-characterized MBLs that 
show numerous hyperfine-shifted resonances between 170 to -80 ppm [227, 234, 235]. For 
instance, the spectra of MIM-1 and MIM-2 are missing the downfield signals at ~-40 ppm, 
previously assigned to secondary metal interactions with proton ligands [227, 234, 235]. 
However, both MIM-1 and MIM-2 display a distinct feature at 45 ppm that has also been 
observed in other MBLs and which was assigned to Co(II)-coordinated NH groups (Figure 
5.9) [120] [236-238]. It was previously proposed, for MBLs from the B1 subgroup, that the 
peak at ~45 ppm may be assigned to the NH protons of the His ligands in the Zn1 site (i.e. 
His116, His118 and His196) [120], residues that are conserved in MIM-1 and MIM-2 (Figure 
1.4 and Figure 4.5). In addition MIM-1 also has a resonance at 120 ppm, which, based on 
metal ion replacement studies, was previously assigned to the NH proton of the only histidine 
ligand in the Zn2 site of the B1 MBL NDM-1 [227]. 
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Figure 5.9. 500 MHz 1H NMR spectra of Co(II) MIM-1 (A) and MIM-2 (B). The spectra 
were acquired in 90% D2O. 
 
MIM-1 has two histidine ligands in that site (i.e. His121 and His263) and hence either or both 
may contribute to the observed resonance.  MIM-2 has ligands identical to those of MIM-1 in 
that site and a similar NMR signal would thus be expected. It is currently not known why the 
resonance is absent but it is yet another demonstration that the family of MBLs may display 
extensive structural flexibility even within the constraints of highly conserved active site 
residues.  This interpretation is further supported when the effect of captopril binding is 
investigated by paramagnetic 1H NMR spectroscopy (Figure 5.9). For MIM-1, in agreement 
with the MCD data, the presence of D-captopril does not affect the spectrum significantly.  In 
contrast, the presence of the inhibitor has a more significant effect on the NMR spectrum of 
MIM-2. The feature at 45 ppm is still present but a faint resonance at ~120 ppm is now also 
visible, suggesting that the Zn2 site has been perturbed by its interaction with D-captopril. 
Thus, it appears likely that this inhibitor, despite binding with similar affinity to MIM-1 and 
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MIM-2 (based on the similarity of the respective Ki values; Chapter 3) and the fact that all of 
the metal ion-coordinating ligands are conserved in the two enzymes, may bind in a different 
orientation. 
In order to gain a better understanding of inhibitor binding the interaction between the metal 
centres of MIM-1 and MIM-2 and D-captopril was further analysed by electron paramagnetic 
resonance (Figure 5.10). 
 
 
 
Figure 5.10. Continuous wave EPR spectra recorded at 20 K in normal perpendicular 
mode at 9.64 GHz.  Data were recorded in absence and presence of D- captopril for MIM-1 
and MIM-2. 
 
 For both MIM-1 and MIM-2 the general features of the spectra are characteristic of a 
bimetallic Co(II) system with five or six ligands (the spectral data for Co(II) systems are not 
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sensitive enough to distinguish between five or six ligands in the coordination environment of 
the metal centres) [120, 226].  The spectra were simulated using the software XSophe (Bruker 
Biospin) by Assoc. Prof. Jeffrey Harmer (Centre of Advanced Imaging; University of 
Queensland), using the parameters listed in Figure 5.11.    
For MIM2 the addition of D-captopril leads to a small shift in the peak positions 
(Figure 5.10), which are indicative of some minor perturbation of the metal ion centre(s).  
However, the shifts are too small to be interpreted accurately by data simulations but do 
suggest that D-captopril interacts weakly with the active site. 
For MIM1 the low field signals (i.e. below 250 mT; Figure 5.10) are essentially 
identical in the absence or presence of the inhibitor. However, in the region between 260 - 
350 mT there is a significant change. The sharp signal at 332 mT, g =2.0715, and the 
hyperfine coupling down to about 260 mT, is probably from a metal-centred radical. Figure 
5.12 shows the power dependence of this signal at 20 K. The lack of signal saturation is 
indicative of a metal-centred radical, not an organic radical molecule. Furthermore, the 
hyperfine resonances in the 260 – 350 mT region could be due to two low spin Co(II) species 
as there would be eight resonances from the metal centre along the gz direction. However, the 
spectrum is not resolved well enough to make an unambiguous assignment, but its formation 
presumably only after addition of D-captopril suggests that D-captopril binds closely 
(directly) to the paramagnetic centre and this interaction perturbs the electronic structure. 
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Figure 5.11. Simulation of the EPR spectra collected for resting MIM-1 (left) and MIM-2 (right).  The spectra were simulated using XSophe 
(Bruker Biospin), assuming H0 = βB0gŜ/ħ+ ŜDŜ, where S = 3/2, D >> βgBS/ħ, and where D > 0 implies the MS = ±1/2 Kramers doublet lies lowest 
and all observed EPR transitions are from this doublet, and D < 0 implies the MS = ±3/2 Kramers doublet lie lowest and all observed EPR transitions 
are from this doublet.  For MIM-1 gx, gy and gz = 2.30, 2.30 and 2.20, respectively, with corresponding linewidths of 1.2, 0.5 and 0.35.  For MIM-2 the 
corresponding values are gx, gy and gz = 2.30, 2.30 and 2.29, respectively, with corresponding linewidths of 1.14, 0.8 and 0.55. 
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Figure 5.12. Power saturation of EPR signals for MIM-1.  Data were measured at microwave powers ranging from 10 db to 50 db for MIM-1 in the 
presence of D-captopril at 20 K. The spectra on the right are showing a close-up focusing on the region between 260 – 350 mT. 
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In summary, EPR data agree, by and large, with MCD and NMR data and suggest that D-
captopril binding may not affect the immediate first coordination sphere significantly. It is 
possible that this inhibitor binds either only to one of the metal ions or none directly, or it 
coordinates via its carboxyl group, not its thiol sulfur, as observed in crystal structures of 
several MBLs.  It is important to point out that the spectroscopic studies, especially the EPR-
related ones, are still preliminary, but as far as comparisons with other MBLs are possible 
MIM-1 and MIM-2 behave similar to those enzymes. Further high-resolution pulse EPR 
experiments (e.g. ENDOR and HYSCORE) aimed at measuring small hyperfine interactions 
between the paramagnetic metal centre and the magnetic nuclei of the D-captopril (i.e. 2H and 
1H nuclei) not resolved in the CW EPR spectra may reveal the position and binding of D-
captopril, but are presently beyond the scope of this work. 
 
5.4 Conclusion 
 
Previous studies probing the effect of pH on the catalytic reaction of MIM-1 and MIM-2 with 
a range of substrates indicated that while there are some variations in terms of preferred pH 
the overall mechanism involving a metal ion-bound nucleophile to initiate the hydrolysis of 
the β-lactam bond appears to remain conserved (see Chapter 3). 
Nitrocefin, a cephalosporin, is a substrate frequently used to probe the mechanism of 
catalysis of MBLs. Interestingly, while nitrocefin is an excellent substrate for both MIM-1 
and MIM-2 no substrate inhibition is observed.  This is in contrast to the behaviour of all 
other substrates tested previously, including cephalosporins (see Fig. 3.2 in Chapter 3). While 
substrate inhibition was interpreted in terms of the presence of an alternative binding site for 
these reactants, nitrocefin may only be able to bind to one site.  Indeed, the Km values of 
MIM-1 and MIM-2 for nitrocefin are of similar magnitude as those of other cephalosporins 
(compare Tables 5.1 and 3.2), indicating that within the active site nitrocefin binds in a 
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manner similar to that of other substrates. This interpretation is also consistent with a recently 
reported similar observation for the B3-type MBL AIM-1, where substrate inhibition is 
common except for nitrocefin [129]. 
  Monitoring the progress of a single catalytic turnover by stopped-flow absorbance 
measurements leads to an apparent discrepancy with the catalytic rate obtained from steady-
state measurements under pseudo first-order conditions.  In fact, the rate of product formation 
appears to be approximately 200-fold slower in a single turnover experiment (~5 s-1 vs ~1000 
s-1; Tables 5.1 and 5.2).  In fact, under single turnover conditions the reactions monitored 
with various metal ion derivatives of both MIM-1 and MIM-2 are very similar, suggesting a 
conserved mechanism.  A plausible explanation for the discrepancy observed for the reaction 
rates monitored under the two different conditions is that in the absence of excess substrate 
the product remains bound to the active site.  However, in the presence of excess substrate, 
due to its higher affinity when compared to that of the product, the substrate displaces the 
product and maintains a rapid catalytic rate. 
 This interpretation may also apply to MBLs such as AIM-1 and Bla2 [120, 129] but 
not to enzymes such as NDM-1 or L1 where single turnover and steady state assays result in 
similar catalytic rates [226, 227], and demonstrates the mechanistic flexibility of MBLs, 
despite largely conserved active site geometries.  Indeed, although no crystal structures of 
MIM-1 and MIM-2 were available before finalising this thesis, spectroscopic data indicated 
that these enzymes have active sites similar to those of other MBLs (Figs 1.4 and 1.5).  
 In summary, while MIM-1 and MIM-2, two MBLs from non-pathogenic 
environmental microorganisms, clearly possess all the features characteristic for this class of 
enzymes they also demonstrate the flexibility of MBLs to perform their reactions.  Of 
particular relevance for the design of potent inhibitors is that product release may be exploited 
to slow down the catalytic rate sufficiently to be of clinical relevance.  In particular, an 
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inhibitor designed to mimic the features of the enzyme-product complex rather than the 
enzyme-substrate complex may prove to be a potent agent in combating antibiotic resistance.  
In order to strengthen this hypothesis, crystal structures of MIM-1 and MIM-2 in complex 
with products may be essential.  Efforts towards this goal are currently in progress in our 
group and will be briefly outlined in the final chapter of this thesis. 
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Chapter 6: Concluding Remarks and Future 
Directions 
 
 The successful treatment of common bacterial infections has been alarmingly 
undermined by the emergence of antibiotic resistance in an ever-increasing number of 
pathogens.  Sustained periods of the haphazard application of antibiotics and global mobility 
have contributed significantly to this global health concern.  The prophylactic use of 
antibiotics in the agricultural industry (supplemented in feed stocks and water sources) is 
another major contributor to the evolution of antibiotic resistance [239, 240]. Since antibiotic 
resistance determinants are frequently located on transposable genetic elements, the chance of 
a horizontal gene transfer connected to urban and environmental microorganisms is a clear 
and real danger [241-243]. In particular, soil environments have been identified as an 
important reservoir of a diversity of antibiotic resistant determinants found in uncultured 
bacteria [244]. Moreover, some soil microorganisms have been shown to contain a wealth of 
antibiotic resistance genes independent of anthropogenic influence [149]. These instances of 
antibiotic resistance in the absence of human intervention offer invaluable and rare insights 
into the origin and evolution of antibiotic resistance prior to the medicinal use of antibiotics, 
insights which may assist future efforts to counteract or prevent antibiotic resistance [244, 
245]. As discussed in Chapter 1, -lactamases are a family of enzymes that have acquired 
considerable notoriety due to their ability to hydrolyse most commonly used -lactam-based 
antibiotics such as penicillins, cephalosporins and carbapenems.  In particular, class B, the so-
called MBLs, are of concern since no clinically useful inhibitors are available. In this context 
MIM-1 and MIM-2, both identified in some environmental marine-based microorganisms, 
harbor tremendous potential to lead research in both the understanding of a powerful 
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antibiotic resistance mechanism and the development of potent drug leads to combat its 
spread. 
An important step towards realizing the potential that MIM-1 and MIM-2 may provide for 
research in the antibiotic resistance area is the elucidation of their three dimensional structures 
by X-ray crystallography.  I initiated crystallization trials during my candidature, establishing 
experimental conditions that led to crystal formations.  None of these crystals were, however, 
of a quality sufficient for diffraction, but they formed a reasonable starting point for further 
optimisations.  Another doctoral student in our group, Mr. Christopher Selleck, recently 
obtained crystals for both enzymes that diffract to resolution of ~2.0 Å (Figure 6.1; C. 
Selleck, unpublished data).   
 
 
 
 
 
 
 
 
Figure 6.1. Crystals grown for MIM-1 (left) and MIM-2 (right) using the hanging drop 
method.  X-ray diffraction data were collected at the Australian Synchrotron in Melbourne at 
resolutions of 2.3 and 1.8 Å, respectively, for MIM-1 and MIM-2.  The structures were solved 
by molecular replacement and model refinement is currently in progress. 
 
The structures of MIM-1 and MIM-2 were readily solved by molecular replacement using the 
coordinates of the B3-type MBL AIM-1 as a template.  Refinements of these structures are 
currently still in progress, but with respect to their overall structure and metal ion binding 
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sites in their catalytic centre they are very similar to other MBLs, as anticipated.  Figure 6.2 
shows the relevant illustration for MIM-2.  It will be interesting to analyse the outer 
coordination spheres of the enzymes as this is the location where the degree of homology 
observed between different MBLs is lower than in the direct coordination sphere.  It is thus 
anticipated that variations in terms of substrate specificity (see Chapters 3 and 4) and 
mechanism (see Chapter 5) are reflected in structural changes in this outer sphere. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2. Partially refined crystal structure of MIM-2 (left).  The red spheres indicate 
the two Zn(II) binding sites in the active centre.  This active site is illustrated on the right, also 
showing the electron density map around the two metal ions (shown as grey spheres).  A total 
of three water molecules (red spheres) complete the first coordination sphere, two terminally 
bound to either of the metal ions (W2 and W3), and one bridging the Zn(II) ions (W1).  W1 is 
the likely hydrolysis-initiating nucleophile in the catalytic cycle of MBLs. 
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Figure 6.3. Thiol derivatives and corresponding inhibition constants (Ki values), 
determined for the B1-type MBL IMP-1. 
 
Our group and others have developed an arsenal of in vitro MBL inhibitors, including a range 
of thiols (Figure 6.3), ketones, alcohols, dicarboxylic acids, sulfates, hydroxamates, tetrazoles 
and sulfonamides [20].  While some of those compounds are potent inhibitors for members of 
one subgroup of MBLs, to my knowledge no “universal” inhibitor that affects representatives 
of ? in a similar manner has yet been developed.  Insofar, the observed plasticity in the active 
site of MIM-1 and MIM-2 may render these enzymes as ideal targets to improve existing 
inhibitor leads, especially with a view to developing the first universally useful MBL 
inhibitor.  Time will tell. 
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Annex: 1 Inteins—A Focus on the Biotechnological  Applications of 
Splicing-Promoting Proteins  
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Abstract  
The main aim of this mini-review is to illustrate strategies and industrial applications 
based on inteins (INTErnal proteINS), which belong to a class of autocatalytic enzymes 
that are able to per- form a catalytic reaction on a single substrate. However, since 
practical applications of inteins are strongly guided by a detailed understanding of their 
biological mechanisms and functions, the first part of this review will thus briefly discuss 
the physiological roles of inteins, describing what is currently known about their 
mechanisms of action. In the second part, specific biotechnological applications of 
inteins will be outlined (i.e. their use for (i) the purification of recombinant pro- teins, 
(ii) the cyclization of proteins and (iii) the production of seleno-proteins), paying 
attention to both potential strengths and weaknesses of this technology.  
Keywords  
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Annex 
 
 
 
 
146 
Annex: 2 Identification and characterization of an unusual metallo-β-
lactamase from Serratia proteamaculans 
 
J Biol Inorg Chem (2013) 18:855–863 DOI 10.1007/s00775-013-1035-z  
ORIGINAL PAPER  
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Abstract Metallo-b-lactamases (MBLs) are a family of metalloenzymes that are capable 
of hydrolyzing b-lactam antibiotics and are an important means by which bacterial 
pathogens use to inactivate antibiotics. A database search of the available amino acid 
sequences from Serratia pro- teamaculans indicates the presence of an unusual MBL. A 
full length amino acid sequence alignment indicates overall homology to B3-type MBLs, 
but also suggests consider- able variations in the active site, notably among residues that 
are relevant to metal ion binding. Steady-state kinetic measurements further indicate 
functional differences and identify two relevant pKa values for catalysis (3.8 for the 
enzyme–substrate complex and 7.8 for the free enzyme) and a preference for penams 
with modest reactivity towards some cephalosporins. An analysis of the metal ion 
content indicates the presence of only one zinc ion per active site in the resting enzyme. 
In contrast, kinetic data suggest that the enzyme may operate as a binuclear enzyme, 
and it is thus proposed that a catalytically active di-Zn2+ center is formed only once the 
substrate is present.  
Electronic supplementary material The online version of this article (doi:10.1007/s00775-013-1035-z) contains supplementary material, 
which is available to authorized users.  
P. Vella E. W. W. Leung F. Ely R. P. McGeary G. Schenk (&) School of Chemistry and Molecular Biosciences, The University of 
Queensland,  
St. Lucia, QLD 4072, Australia e-mail: schenk@uq.edu.au  
M. Miraula E. Phelan N. Mitic  ́(&) Department of Chemistry, National University of Ireland, Maynooth, Maynooth, Co. Kildare, Ireland e-
mail: natasa.mitic@nuim.ie  
D. L. Ollis Research School of Chemistry, The Australian National University, Canberra, ACT 0200, Australia  
R. P. McGeary School of Pharmacy, The University of Queensland, St. Lucia, QLD 4072, Australia  
Keywords Antibiotics resistance Metallo-b- lactamases Binuclear metallohydrolases Sequence homology Infectious disease  
 
Annex 
 
 
 
 
147 
Annex: 3 Intrinsic disorder and metal binding in UreG proteins from 
Archae hyperthermophiles: GTPase enzymes involved in the activation of 
Ni(II) dependent urease 
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Abstract Urease is a Ni(II) enzyme present in every domain of life, in charge for 
nitrogen recycling through urea hydrolysis. Its activity requires the presence of two 
Ni(II) ions in the active site. These are delivered by the concerted action of four 
accessory proteins, named UreD, UreF, UreG and UreE. This process requires protein 
ex- ibility at different levels and some disorder-to-order transi- tion events that 
coordinate the mechanism of protein–pro- tein interaction. In particular, UreG, the 
GTPase in charge of nucleotide hydrolysis required for urease activation, presents a 
signi cant degree of intrinsic disorder, exist- ing as a conformational ensemble featuring 
characteristics that recall a molten globule. Here, the folding properties of UreG were 
explored in Archaea hyperthermophiles, known to generally feature signi cantly low 
level of structural dis- order in their proteome. UreG proteins from Methanocal- 
dococcus jannaschii (Mj) and Metallosphaera sedula (Ms) were structurally and 
functionally analyzed by integrating circular dichroism, NMR, light scattering and 
enzymatic assays. Metal-binding properties were studied using iso- thermal titration 
calorimetry. The results indicate that, as the mesophilic counterparts, both proteins 
contain a signi - cant amount of secondary structure but maintain a exible fold and a low 
GTPase activity. As opposed to other UreGs, secondary structure is lost at high 
temperatures (68 and 75 °C, respectively) with an apparent two-state mechanism. Both 
proteins bind Zn(II) and Ni(II), with af nities two 1 orders of magnitude higher for 
Zn(II) than for Ni(II). No major modi cations of the average conformational ensem- ble 
are observed, but binding of Zn(II) yields a more com- pact dimeric form in MsUreG.  
Keywords Intrinsically disordered enzyme · UreG · Urease · Metal binding · Archaea thermophiles  
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Annex: 4 Identification and preliminary characterization of novel B3-type 
metallo-β-lactamases 
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ABSTRACT  
Antibiotic resistance has emerged as a major global threat to human health. Among the 
strategies em- ployed by pathogens to acquire resistance the use of metallo-β-lactamases 
(MBLs), a family of dinuclear metalloenzymes, is among the most potent. MBLs are 
subdivided into three groups (i.e. B1, B2 and B3) with most of the virulence factors 
belonging to the B1 group. The recent discovery of AIM-1, a B3-type MBL, however, 
has illustrated the potential health threat of this group of MBLs. Here, we employed a 
bioinformatics approach to identify and characterize novel B3-type MBLs from 
Novosphingobium pentaro- mativorans and Simiduia agarivorans. These enzymes may not 
yet pose a direct risk to human health, but their structures and function may provide 
important insight into the design and synthesis of a still elusive universal MBL inhibitor.  
Keywords: Antibiotic Resistance; β-Lactam Antibiotics; Metallo-β-Lactamases; Sequence 
Homology; Novosphingobium Pentaromativorans; Simiduia Agarivorans  
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Abstract  
Antibiotic resistance is one of the most significant challenges facing global healthcare. 
Since the 1940s, antibiotics have been used to fight infections, initially with penicillin 
and subsequently with various derivatives including cephalosporins, carbapenams and 
monobactams. A common characteristic of these antibiotics is the four-membered β-
lactam ring. Alarmingly, in recent years an increasing number of bacteria have become 
resistant to these antibiotics. A major strategy em- ployed by these pathogens is to use 
Zn(II)-dependent enzymes, the metallo-β-lactamases (MBLs), which hydrolyse the β-
lactam ring. Clinically useful MBL inhibitors are not yet available. Conse- quently, 
MBLs remain a major threat to human health. In this review biochemical properties of 
MBLs are discussed, focusing in particular on the interactions between the enzymes and 
the func- tionally essential metal ions. The precise role(s) of these metal ions is still 
debated and may differ between different MBLs. However, since they are required for 
catalysis, their binding site may present an alternative target for inhibitor design.  
Keywords  
Antibiotic Resistance, β-Lactam Antibiotics, Metallo-β-Lactamases, Reaction Mechanism, 
Metal Ion Binding  
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Abstract  
At least one-third of enzymes contain metal ions as cofactors necessary for a diverse 
range of catalytic activities. In the case of polymetallic enzymes (i.e., two or more metal 
ions involved in catalysis), the presence of two (or more) closely spaced metal ions gives 
an additional advantage in terms of (i) charge delocalisation, (ii) smaller activation bar- 
riers, (iii) the ability to bind larger substrates, (iv) enhanced electrostatic activation of 
substrates, and (v) decreased transition-state energies. Among this group of proteins, 
enzymes that catalyze the hydrolysis of ester and amide bonds form a very prominent 
family, the metallohydrolases. These enzymes are involved in a multitude of biological 
functions, and an increasing number of them gain attention for translational research in 
medicine and biotechnology. Their functional versatility and catalytic proficiency are 
largely due to the presence of metal ions in their active sites. In this chapter, we thus 
discuss and compare the reaction mechanisms of several closely related enzymes with a 
view to highlighting the functional diversity bestowed upon them by their metal ion 
cofactors.  
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Abstract Metallo-β-lactamases (MBLs) are a family of Zn(II)-dependent enzymes that 
inactivate most of the com- monly used β-lactam antibiotics. They have emerged as a 
major threat to global healthcare. Recently, we identi ed two novel MBL-like proteins, 
Maynooth IMipenemase-1 (MIM-1) and Maynooth IMipenemase-2 (MIM-2), in the 
marine organisms Novosphingobium pentaromativorans and Simiduia agarivorans, 
respectively. Here, we dem- onstrate that MIM-1 and MIM-2 have catalytic activities 
comparable to those of known MBLs, but from the pH dependence of their catalytic 
parameters it is evident that both enzymes differ with respect to their mechanisms, with 
MIM-1 preferring alkaline and MIM-2 acidic conditions. Both enzymes require Zn(II) 
but activity can also be recon- stituted with other metal ions including Co(II), Mn(II), 
Cu(II) and Ca(II). Importantly, the substrate preference of MIM-1 and MIM-2 appears 
to be in uenced by their metal ion composition. Since neither N. pentaromativorans nor 
S. agarivorans are human pathogens, the precise biologi- cal role(s) of MIM-1 and MIM-
2 remains to be established. However, due to the similarity of at least some of their in 
vitro functional properties to those of known MBLs, MIM-1 and MIM-2 may provide 
essential structural insight that may guide the design of as of yet elusive clinically use- 
ful MBL inhibitors.  
 
Electronic supplementary material The online version of this article (doi:10.1007/s00775-
015-1250-x) contains supplementary material, which is available to authorized users.  
Keywords Antibiotic resistance · β-Lactam antibiotics · Metallo-β-lactamase · 
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Abstract MIM-1 and MIM-2 are two recently identified metallo-β-lactamases (MBLs) 
from Novosphingobium pentaromativorans and Simiduia agarivorans, respectively. 
Since these organisms are non-pathogenic we specu- lated that the biological role(s) of 
MIM-1 and MIM-2 may not be related to their MBL activity. Although both se- quence 
comparison and homology modeling indicate that these proteins are homologous to well-
known MBLs such as AIM-1, the sequence analysis also indicated that MIM-1 and 
MIM-2 share similarities with N-acyl homoserine lactonases (AHLases) and glyoxalase 
II (GLX-II). Steady-state kinetic assays using a series of lactone substrates confirm that 
MIM-1 and MIM-2 are efficient lactonases, with catalytic efficiencies resembling those 
of well-known AHLases. Interestingly, unlike their MBL activity the AHLase activity of 
MIM-1 and MIM-2 is not dependent on the metal ion composition with Zn(II), Co(II), 
Cu(II), Mn(II) and Ca(II) all being able to reconstitute catalytic activity (with Co(II) 
being the most efficient). However, these enzymes do not turn over S-lactoylglutathione, 
a substrate characteristic for GLX-II activity. Since lactonase activity is linked to the 
process of quorum sensing the bifunctional activity of “non-pathogenic” MBLs such as 
MIM-1 and MIM-2 may provide insight into one possible evolutionary pathway for the 
emergence of antibiotic resistance.  
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ABSTRACT  
Metallo-β-lactamases (MBLs) are a family of Zn
2+
- dependent enzymes that have 
contributed strongly to the emergence and spread of antibiotic resistance. Novel 
members as well as variants of existing mem- bers of this family are discovered 
continuously, com- pounding their threat to global health care. MBLs are divided into 
three subgroups, i.e. B1, B2 and B3. The recent discovery of an unusual MBL from 
Serratia proteamaculans (SPR-1) suggests the presence of an additional subgroup, i.e. 
B4. A database search re- veals that SPR-1 has only one homologue from Cro- nobacter 
sakazakii, CSA-1.These two MBLs have a unique active site and may employ a 
mechanism dis- tinct from other MBLs, but reminiscent of some or- ganophosphate-
degrading hydrolases.  
KEYWORDS  
Antibiotic Resistance; β-Lactam Antibiotics; Metallo-β-Lactamases; Sequence 
Homology; Serratia proteamaculans; Cronobacter sakazakii  
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